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ABSTRACT
There is a growing epidemic of obesity in the United States and a
corresponding increase in the number of morbidly obese patients receiving healthcare.
Despite the increasing focus and research on obesity over the years, the prevalence of
obesity in the United States has continued to worsen. A stigma against obesity exists
in the general public including among healthcare professionals. Attitudes and bias of
healthcare professionals against obesity can negatively affect judgment and choices
related to the enactment of care, affecting both the quality of healthcare delivered and
patient outcomes. Studies have shown that stigmatization against groups of patients
such as minorities affects healthcare outcomes, however there is a paucity of research
related to outcomes of stigmatization against obese individuals. The purpose of the
study was to determine if there is a difference in quality of nursing care as measured
by medicating for pain between obese and non-obese post-surgical patients. It was
hypothesized that obese individuals will receive less pain medication than non-obese
individuals. An underlying assumption based on the literature was that stigmatization
of obesity by nurses would be reflected in reduced administration of post-surgical pain
medication. The greater the stigma present, the less pain medication will be
administered.
This study used a retrospective chart review of the electronic medical record of
three hospitals within a single healthcare system to compare non-bariatric postsurgical pain treatment among normal weight, over-weight, and obese adult patients as
a measure of nurses’ stigma. The final data set contained a total of 1704 cases, with
21.4% (n=365) normal weight, 21.4% (n=365) overweight, 21.4% (n=365) obesity

class I, 17.1% (n=291) obesity class II, and 18.7% (n=318) obesity class III
individuals. BMI scores ranged from 18.5 to 185.9 (M = 33.1, SD = 11.1). Findings
showed differences in total dose of day one post-surgical pain medication among the
normal, overweight, obesity class I, II, and III patients. Obesity class III patients
received less pain medication than the obesity class I and class II patients and
significantly less than the overweight patients. Simple linear regression analyses were
used to determine the relationship between BMI and pain medication administration
on postoperative day one and day two. Hierarchical linear regression was used to
determine the relationship between dose on day one and day two and BMI, while
taking into account other variables associated with stigma. The relationship between
dose of pain medications and BMI was significant and negatively related. For every
1% increase in BMI there was a .17% decrease in the total morphine equivalent dose
of narcotic given on postoperative day one. When controlling for other factors related
to stigma, there was a .25% decrease in dose for every 1% increase in BMI. Further
research is needed to measure attitudes and biases of nurses along with their
administration of pain medication to obese patients. Addressing nurses’ stigma of
obesity is essential to improving the quality of care of obese patients.
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CHAPTER 1

INTRODUCTION

There is a growing epidemic of obesity within the United States (U.S.) as
described by the Center for Disease Control and Prevention’s (CDC) Behavioral Risk
Factor Surveillance System from 1990 to 2007 (Center for Disease Control and
Prevention, 2008). In 1990, no states had an obesity prevalence of greater than or
equal to 15%. By 2007, 30 states had an obesity prevalence of greater than or equal to
25% and three states had a prevalence of greater than or equal to 30%. In 2013, no
state had a prevalence of obesity less than 20%, 23 states were between 25% and 30%,
18 states between 30% and 35%, and 2 states (Mississippi and West Virginia) had a
prevalence of obesity of 35% or greater. The South had the highest prevalence of
obesity (30.2%), followed by the Midwest (30.1%), the Northeast (26.5%), and the
West (24.9%) (Center for Disease Control and Prevention, 2015). More than one-third
(78.6 million) of U.S. adults are obese.
Over the past decade, there has also been an increase in the number of
morbidly obese patients receiving healthcare. This can be seen be examining the
literature regarding bariatric surgery. Between 1998 and 2004, there has been
approximately an 900% increase (13,386 in 1998 to 121,055 in 2004) in the number of
bariatric surgeries, such as gastric bypass and banding procedures, performed (Zhao &
Encinosa, 2007). The increase in bariatric surgeries is alarming because it suggests
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that there has been a dramatic increase in the number of surgical patients who qualify
(i.e., are morbidly obese) for bariatric procedures.
Attitudes and bias of healthcare professionals against obesity can negatively
affect judgment and choices related to the enactment of care, affecting both the quality
of healthcare delivered and patient outcomes. Stigmatization of obesity has been
described as having a negative impact on health and there are a few studies that have
shown that obese individuals receive inferior healthcare when compared to that of
normal weight individuals. For example, obese patients were less likely to receive pap
smears, mammograms, and colorectal cancer screenings (Fagan, Wender, Meyers &
Petrelli, 2011), as well as cervical and breast cancer screenings (Wee, McCarthy,
Davis & Phillips, 2000). Physicians spend less time with these patients and were
found to only give patients a separate diagnosis of obesity 14.4% of the time (Huang
et al., 2004, Bleich, Pickett-Blakely & Cooper, 2011). This lack of a separate
diagnosis was an important finding because obese patients were less likely to receive
weight loss counseling or education without a diagnosis (Tsai & Wadden, 2009).
It is important to study the effect of obesity on healthcare and health outcomes
because of the magnitude of individuals that are affected. In order to promote the best
health outcomes in obese individuals, it is important to not only describe the
stigmatization of obesity that occurs, but also to identify the consequences of that
stigma. Despite this increasing focus and research on obesity over the years, the
prevalence of obesity in the United States has worsened. Even with this attention,
obese individuals still must access healthcare and stigma still exists among healthcare
providers. There are research studies that show that stigmatization against other
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groups of patients affects healthcare outcomes, but no studies could be found that were
related to outcomes of stigmatization against obese individuals related to the treatment
of pain. If stigmatization against obese patients and resultant reduction in the quality
of healthcare can be documented, then interventions to reduce bias and improve
healthcare for obese patients can be developed.
Purpose of Research
The purpose of the study is to determine if there is a difference in quality of
nursing care as measured by medicating for pain between normal, overweight, and
obesity class I, II, and III post-surgical patients. Treatment of pain is an important
quality indicator for hospitals and effective treatment is a requirement of accreditation
by the Joint Commission. The amount of pain medication received has been studied in
other stigmatized groups, for example racial bias resulting in less pain medication
received in the emergency department, but this has never been studied in relation to
obesity stigma. It is hypothesized that there is a difference in the amount of pain
medication administered between normal, overweight, obesity class I, II, and III
patients that results from stigmatization of obesity by nurses The greater the stigma
present, the less pain medication is administered.
Research Questions. The research questions for this study are:
1. What is the difference in the total morphine equivalent dose of post-surgical
pain medication administered between normal weight, overweight, and obese
(Class I, II, and III) adult non-bariatric surgery patients?
2. What is the relationship between pain medication ordered and administered
and the BMI of adult non-bariatric surgery patients?
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3. What is the relationship between patients’ BMI and the receipt of post-surgical
pain medication, when accounting for race, gender, age, insurance status,
presence of psychiatric diagnosis, and pain score during hospitalization?
Significance of the Study
This problem was selected because of the increase in obesity in the United
States and the increase in the number of obese individuals seeking healthcare.
Stigmatization of obesity has no place in healthcare because of the potential to impact
the lives of millions of individuals and increase healthcare costs. This study is
important because it could contribute to an improvement in quality of care, decrease in
healthcare costs, and an increase in quality of life of obese individuals. The study has
personal importance due the researcher’s twenty-year nursing career in the operating
room and being witness to the increased need for consideration of obese patients
during care surrounding surgery.
Theory
Symbolic interaction is a useful theory in the development of knowledge
related to obesity stigma because it can be used to generate a wide range of
researchable hypotheses. Meaning is a central to understanding stigma and its effect
on health outcomes. The meaning that nurses attribute to obesity can shape their
definitions of situations and perspectives towards the patient. Studying these meanings
and the ways of helping individuals to reappraise attitudes and definitions of situations
may reduce stigma. The processes of symbolic interaction are useful in describing the
range of reference groups utilized by nurses in healthcare, how perspectives and
stigma arise within these groups, how these perspectives shape nursing practice, and
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how they may change. The focus of future nursing research related to obesity stigma
should be on understanding how negative perspectives arise and removing them by
altering perspectives and definitions of situations, which should in turn remove
stigmatizing actions and improve care provided to obese patients.
Premises and Assumptions
Premise 1. A major premise of symbolic interaction, and this study, is that
nurses act toward obese patients based on the meaning they attach to being obese.
Negative bias or stigma would be reflected in a reduced pain medication
administration. If nurses attach being lazy or lack of self-control to obesity, then
biased attitudes may occur.
Premise 2. Another premise is that this meaning arises through interaction
with others, for example medical students interacting with biased residents and
physicians, or through observing the interactions of others in person or through the
media. Negative attitudes toward and interactions with obese individuals can be seen
daily through mass media.
Premise 3. The final premise is that meanings are assigned and modified
through an interpretive process. The meaning that individuals attach to things is
constantly changing. This can be seen in studies that described less negative attitudes
towards obesity in individuals who are educated about the uncontrollable causes of
obesity.
Assumption. The major assumption of this study is that stigma of obesity is
not just an attitude or bias, but translates into behaviors that effect the provision of
care given by healthcare providers, meaning that there is a lower quality of care
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provided to obese as compared to normal-weight individuals. This assumption reflects
Premise 1 of Symbolic Interaction, whereby the meaning attached to something is
reflected in actions toward it.
Study Design
Treatment of pain was used as an indicator of obesity bias/stigmatization
among healthcare providers in this study. A retrospective chart review was performed
that examined data from the data warehouse of a large Rhode Island healthcare
system. The warehouse consists of multiple data bases that save data from the multiple
electronic medical record applications that are used within the system. Data for this
study was collected specifically from the medication administration, the admitting,
and the computerized physician order entry application. Data from these systems will
be utilized to determine any differences or relationships between a patient’s weight
status, as measured by their body mass index (BMI), and the amount of postoperative
pain medication they receive. The five BMI categories used in this study were
determined based on classification by the Centers for Disease Control (2015) of
normal (18.5 – 24.9), overweight (25 – 29.9) and the World Health Organization
(2014) obesity class I (30 – 34.9), II (35 – 39.9), and III (≥40). The association of
treatment of pain to obesity stigma has not been studied, but has been studied with
other stigmatized groups, for example in minorities (Pletcher, Kertesz, Kohn &
Gonzoles, 2008; Sabin & Greenwald, 2012).
Summary of Chapters to Follow
In chapter 2, a review of the literature describes the concept of stigma and
defines its properties. The prevalence of obesity stigma in healthcare and its effect on
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patient care delivered by various types of healthcare providers is reviewed. Various
theoretical approaches, and study designs are described. Chapter 3 describes the
research design of this study, highlighting the sampling method and the variables
chosen. It is important to understand why the variables were chosen and how they
could account for other stigmatizing conditions, besides obesity, that may impact pain
medication administration. Chapter 4 presents the research findings and reports the
results from a one-way ANOVA to compare differences in medication administration,
Chi Square to examine relationships between medication ordering and medication
between the BMI categories, and regression analyses to determine the relationship
between BMI and pain medication administration, while controlling for other variables
identified as being associated with bias or stigma. Chapter 5 presents the discussion of
the findings, limitations of the study, as well as implications for nursing research,
practice, and education.
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CHAPTER 2

REVIEW OF LITERATURE

Concept of Stigma
To “stigmatize” has been defined as to describe or identify in opprobrious
(vulgar, slanderous, abusive) terms (Merriam-Webster.com, 2013). Link & Phelan
(2001) described stigmatization as the convergence of distinguishing and labeling
human differences, linking labeled persons to negative stereotypes, separating “them”
from “us”, and status loss and discrimination of the labeled person which co-occur in a
power situation that allows the components of stigma to unfold.
Stigma, and the resulting stigmatization, is a complicated, multifactorial
concept that was first comprehensively examined in the works of Goffman (1963), and
later adapted for various situations in psychology, sociology, and various healthcare
professional literatures. Stigma has been much studied, but a unified definition
remains elusive. Many studies provide no explicit definition, or they quote Goffman’s
definition where stigma is an attribute that is deeply discredited (stigmatized). Many
studies deconstruct stigma into a list of attributes possessed by the stigmatized, and do
not examine it as a language of relationships (Goffman, 1963). The reason for this
definitional ambiguity may be the fact that the study of stigma has been
multidisciplinary and each discipline has applied a slightly different definition in order
to fit a wide variety of professional lenses and situations (Link & Phelan, 2001).
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Multiple definitions for this concept may be appropriate given the different research
questions being asked, but it does contribute to confusion regarding stigma.
The concept of stigma related to obesity can be defined by describing the
stigma, the attitudes and biases related to the stigma, and the effect stigma has related
to healthcare. The stigma of obesity sets individuals apart from those who are not
obese. The stigma connotes a set of negative attributes for which an obese individual
is stigmatized. The obese individual is seen in a negative light due to deficient morals,
which causes others to act differently toward the individual. Stigmatization is less
likely to occur if there is a perceived cause for the obesity. Research has been
conducted that shows that the non-obese react more favorably to obese individuals
only if they perceive that the excess weight is beyond the control of the individual, for
example the presence of a thyroid condition. This sets up a condition of inequality
where those who are perceived to lack control of themselves and do not have any
biological excuse for being overweight will be treated less favorably. In a review of
literature, Wright & Whitehead (1987) found that fatness was stereotyped and that the
more it was perceived that an individual was responsible for their obesity, the more
they were disliked. Obese individuals who presented with a condition, such as a
thyroid problem, were judged as more likeable, having more self-control, and were
judged more attractive than obese individuals who did not have a physical cause to
their obesity (DeJong, 1980). Individuals who were educated regarding the
controllable causes of obesity are more likely to endorse negative stereotypes than are
individuals who were educated about the uncontrollable causes (Puhl, Schwartz &
Brownell, 2005).
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The nature of stigma is that it is present among groups that exist outside the
societal norm. Crocker & Major (1989) described stigmatization as occurring towards
oppressed social categories of people toward which others hold negative attitudes,
stereotypes, and beliefs, who are vulnerable to being labeled as deviant, and are who
targets of prejudice or victims of discrimination. The recipients of stigmatization
receive a disproportionately poor interpersonal or economic outcome relative to
members of the society at large. Also, a stigmatized group is an out group relative to
the dominant group in a culture or society, whereas an out group is defined by
reference to any particular in-group, regardless of which group holds the dominant
position in the social hierarchy. Puhl & Brownell (2003) suggested that a stigmatized
person possesses an attribute or characteristic that conveys a social identity that is
devalued in some particular social context. Puhl & Brownell (2006) also associated
stigmatization with weight bias and stereotyping. Balogh-Robinson (2011) described
stigmatization as a weight bias, prejudice, discrimination, or stereotype. Stigmatization
occurs when any personal attribute is deeply discredited to its possessors; including
“tribal stigmata,” “abominations of the body,” and “blemishes of individual character”
(Goffman, 1963). Goffman also described it as the relationship between an attribute
and a stereotype. Lewis & Van Puymbroeck (2008) described stigmatization as the
discriminatory acts that result from the social disapproval tied to existing negative
attitudes toward people perceived as being overweight.
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Stigma and Healthcare
Prevalence. The prevalence of stigma as described within the literature
encompasses many examples of socially unacceptable conditions which are
stigmatized. In performing a literature search using the Cumulative Index to Nursing
and Allied Health Literature (CINAHL) database and “stigmatization” as a key word,
601 results were returned that were published between 1987 and 2013. A vast majority
of the literature on stigmatization during this time period was related to mental illness
and HIV infection. Stigmatization in obese individuals is the area of interest for this
author. There is very little research of this facet of the stigma concept. Performing a
literature search using CINAHL and “stigmatization” and “obesity” as keywords
returned 29 results between published between1994 and 2013. Most of the articles
focused on the attributes of stigma and the effects of stigmatization of obese
individuals.
Groups affected by stigma. Stigma associated with certain groups requiring
healthcare is very prevalent within society. It is described as affecting multiple groups
of individuals and occurs in every culture. Stigma has been described within multiple
groups, such as stigma related to HIV/AIDS (Herek, Capitanio &Widaman, 2002;
Letamo, 2003; Vanable, Carey, Blair & Littlewood, 2006), mental illness (Alonso et
al., 2009; West et al., 2011), illicit drug use (Ahern, Stuber & Galea, 2007), epilepsy
(Jacoby & Austin, 2007), smokers (Stuber, Galea & Link, 2008), and skin disorders
(Chaturvedi, Singh & Gupta, 2005). The common thread that these different types of
stigma share with obesity stigma is that the individual possesses and/or displays a
mark or behavior that identifies them as belonging outside what is normal or
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acceptable in society. Stigmatization of a group occurs whether it is perceived that the
stigma may or may not be the fault of the individual.
The characteristics of stigma are typically defined by the attributes being
stigmatized. Stigma related to HIV is associated with homosexuality, promiscuity, and
drug use. Stigma related to mental illness can be associated with inappropriate or
bizarre behaviors, instability, and lack of personal hygiene. Stigma related to drug use
is associated with lack of morals, criminal behavior, and drug addiction as a disease.
The stigma of epilepsy is characterized by having a perceived mental illness, being
possessed, and lacking intelligence. Stigma related to smoking is associated with
lacking willpower and putting one’s health, or another’s health, at risk. Stigma related
to skin diseases is associated with being unclean. Characteristics of stigma such as
controllability, concealability, and entitativity, greatly affect psychological and
behavior reactions to the stigma (Major & O’Brien, 2005) If the stigma is controllable,
then individuals are more likely to possess negative attitudes and bias toward the
stigma. Stigma that is concealable is less likely to be stigmatized, yet individuals may
feel shame and may spend considerable effort trying to hide stigmatized attributes.
Entitativity relates to the cohesiveness of a group. The presence of stigmatized
attributes can activate stereotypic beliefs that cause them to be considered not only
physically, but psychologically similar to other members of the group. For example,
the stereotypic belief that obese individuals are lazy and lack willpower may be
applied to all obese individuals.
Effects of stigma. Stigma can greatly affect an individual who is stigmatized
and multiple consequences that can occur. Stigma has been described as decreasing
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self-esteem, lowering academic achievement, and placing an individual at greater risk
for mental and physical health problems (Major & O’Brien, 2005). Link & Phelan
(2006) described stigma as affecting employment opportunities, housing, access to
medical care, and exposure to chronic stress. Holzemer et al. (2009) described the loss
of social support, persecution, isolation, job loss and problems accessing healthcare
services resulted from stigma. Self-esteem has been found not to decrease in
stigmatized individuals proportionally to the amount they are devalued by society.
Crocker, Cornwell & Major (1993) described that self-esteem in overweight women
may be increased by externalization of the cause of negative feedback, moving away
from blaming oneself. Those who internalized the causes of negative feedback
demonstrated lower self-esteem. In academic achievement, stigmatized individuals
may receive less attention and support. Stigmatization directly affects health exposing
individuals to physical and social environments that are more toxic and stressful and
by limiting their access to quality medical care.
Stigma of obesity related to healthcare professionals. Negative attitudes and
beliefs related to obesity exist in the literature among healthcare students and
professionals. Negative or biased attitudes, such as slow, like food, overeat, are
insecure, and have low self-esteem, were described as present in physician assistant
students (Wolf, 2010) where 13.6% of the physician assistant students studied
displayed a high level of fat phobia. Waller, Lampman & Lupfer-Johnson (2012)
described weight bias in nursing and psychology students. Both student groups
displayed a significant implicit weight bias that was greater towards women than men.
Nursing students were also described as having fat phobia and negative attitudes
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toward obese patients (Poon & Tarrant, 2009). Registered nurses were compared to
nursing students in the study and had a significantly greater fat phobia. Both groups
perceived obese people as liking food, over eaters, shapeless, slow, and unattractive.
Dietetic students were more likely to describe a poor health status and diet quality
towards obese patients, even with identical health profiles among all individual
scenarios (normal and overweight)(Puhl, Wharton & Heuer, 2009). These students
displayed a moderate amount of fat phobia and rated obese patients as less likely to
comply with treatment. Persky & Ecclesten (2011) described that medical students
displayed more negative stereotyping towards obese patients, as well as rating them
less likely to comply with treatment recommendations. Students attributed more
responsibility to obese patients for potentially weight-related health problems. Few
medical students who have fat bias are aware of this bias (Miller et al., 2013). Due to
the common lack of explicit bias in healthcare providers, other measures are needed to
determine the presence of implicit bias. This could be accomplished with use of a
scale that measures implicit bias in combination with a measure of patient outcomes
among stigmatized and non-stigmatized groups. The presence of stigmatization in
healthcare students is disturbing because of the potential that they will carry these
attitudes and biases forward into practice. There may be a great opportunity to change
attitudes in healthcare by focusing more study on students. This lack of bias awareness
also holds true for other healthcare providers, such as physicians. A review of studies
measuring implicit bias in physicians towards stigmatized groups found that obese,
black, Hispanic, elderly, and women patients were the target of more bias (Chapman,
Kaatz & Carnes, 2013).
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Hebl & Xu (2001) described physician responses to mock medical records of
patients who were average, overweight, and obese presenting with a migraine
headache. Physicians viewed heavier patients more negatively and reported that they
would spend less time with them than average weight patients. Physicians were more
likely to perceive their obese patients as non-adherent to medications (Huizinga et al.,
2010), which has been shown in other studies to affect physician prescribing patterns.
Patients perceived as non-adherent may not receive guideline recommended care and
may result in a delay in prescribing recommended medications for HIV, acute
coronary syndrome, and hemophilia, or intensifying therapy for diabetes. A clinician’s
own body weight also affects healthcare received. Patients reported less confidence in
care provided by overweight physicians (Hash, Munna, Vogel & Bason, 2003) and
thin and overweight pediatricians reported more difficulty with weight loss counseling
than average weight physicians (Perrin, Flower & Ammerman, 2005). Attitudes and
bias of healthcare professionals towards obesity are often not explicitly demonstrated,
but implicit (Schwartz et al., 2003). The stigma of obesity may affect healthcare
professionals and create implicit bias. This can negatively affect judgment and choices
related to the enactment of care, affecting both the quality of healthcare delivered and
patient outcomes, as described by several research studies (Ǿstbyte, Taylor, Yancy &
Krause, 2005; Tsai & Waden, 2009; Bertakis & Azari, 2005; Huang et al., 2004). To
improve patient outcomes, healthcare providers should raise their awareness of any
implicit bias.
Obesity stigma and healthcare outcomes. Stigmatization of obesity has been
described as having a negative impact on health and healthcare. Many studies have
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shown that obese individuals receive inferior healthcare when compared to normal
weight individuals, such as less screenings for mammography or Pap smear (Ǿstbyte
et al., 2005). In a review of literature, Fagan, Wender, Meyers & Petrelli (2011)
described a negative association between weight and pap smears, mammography, and
colorectal cancer screenings. Overweight and obese women were described as less
likely to be screened for cervical and breast cancer (Wee, McCarthy, Davis & Phillips,
2000). Tsai & Wadden (2009) described absence, or less than recommended weight
loss counseling in obese patients. Bertakis & Azari (2005) found that primary care
physicians spent less time educating their obese patients about their health and spent a
greater portion of the visits on technical tasks, such as history taking, performing the
physical examine, giving feedback and planning treatment, and performing in-office
procedures than with non-obese patients. Huang et al. (2004) found that obesity was
documented as a separate clinical diagnosis in only 14.4% of patients with a BMI of
30 or higher. Patients who did receive a diagnosis were more likely to receive weight
counseling compared to those did not. Obese patients without a diagnosis are often
counseled regarding their weight only if they have other health issues. Patients with a
body-mass index (BMI) ≥ 35 or with Type 2 diabetes were more likely to report being
counseled to lose weight than those without diabetes or patients with < 35 BMI. Obese
patients often do not receive an obesity diagnosis (Bleich, Pickett-Blakely & Cooper,
2011). While diet and exercise counseling were more likely to occur with a diagnosis
of obesity, pediatric care providers were more likely to provide diet and exercise
counseling than other specialties, including family physicians and general practice
providers (Cook, Weitzman, Auinger & Barlow, 2005).
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Postoperative Pain. This study examined the treatment of postoperative pain
and its relationship to a patient’s BMI. Postoperative pain is an important topic to
study since it has significant effects on health outcomes, such as increased lengths of
hospital stay and delays in returning to activities of daily living (Morrison et al.,
2003). Pain greatly affects the patient’s ability to ambulate and immobility has been
described as increasing 6-month mortality rates (Siu et al., 2006), while early
ambulation has been associated with quicker return of functional capacity and a
greater discharge to home after surgery (Oldmeadow et al., 2006). Mental status
decline in geriatric patients has also been described in relation to the presence of
postoperative pain (Lynch et al., 1998; Duggleby & Lander, 1994). A decrease in
postoperative myocardial ischemia has been found in elderly patients receiving
effective pain control after surgery (Scheinin et. al, 2000).
Stigma and treatment of pain in other stigmatized conditions. While the
study of bias and its effect on the treatment of pain has not been studied in obese
patients, it has been studied as it relates to other groups. Stigma related to the
provision of healthcare and the treatment of pain has been described in association
with age, gender, race, and mental illness.
Studies have described that age is a factor in receiving analgesia, with older
adult patients receiving less than younger patients (Jones, Johnson & McNinch, 1996).
Also, several other age-related factors have been described among older adult patients
that may affect the administration of pain medication, such as challenges of
assessment of pain in older adults, the under reporting of pain, atypical manifestation
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of pain in older patients, and misconceptions regarding tolerance and addiction
(Cavalieri, 2005).
Women experiencing more severe pain than men (Cepeda & Carr, 2003), and a
gender bias has been describe in pain management, with women receiving more
analgesia than men (Fillingim et al., 2009). In a review of the literature, Hoffmann &
Tarzian (2001) found that women were less likely to be taken seriously and receive
adequate treatment for pain. Pain was often ascribed to psychiatric causes in women.
In a study examining the effect of race and gender on physician pain management
decisions, Weisse, Sorum & Dominguez (2003) found that physicians treat women
less aggressively for pain.
In studies related to bias and race, treatment of pain has been demonstrated to
be less in minorities than in white patients (Pletcher et al., 2008; Sabin & Greenwald,
2012) and in black patients, unless they exhibited demanding or angry behavior
(Burgess et al., 2008). Mills et al. (2011) described that nonwhite patients who
presented to the ED for pain were less likely than whites to receive analgesia and
waited longer for their opiate medication. Pletcher et al. (2008) described differential
prescribing of opioids by race/ethnicity for all types of pain. In a study examining the
effect of implicit bias on pediatric physicians’ treatment recommendations, Sabin &
Greenwald (2012) found an association between implicit bias and patient’s race in
prescribing a narcotic medication for pain following surgery. It is possible that
treatment of pain may also be lacking in other stigmatized groups, such as in obese
patients.
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Insurance status has been used in multiple studies (Vijayakumar, et al., 1995;
Hong, Baumann, & Boudreaux, 2007) as an indicator of socioeconomic status. Bird &
Bogart (2000) have described it as a perceived reason for discrimination during
healthcare provision.
Having a psychiatric diagnosis is a stigmatized condition and is associated with
poorer healthcare outcomes (Zolnierek, 2009). Patients with psychiatric diagnoses
often have their physical health problems attributed to their mental illness
(Thornicroft, Rose & Kassam, 2007). Primary care providers have been described as
having significantly increased negative attitudes towards patients with mental illness,
as described by the presence of stereotyping and attributing of negative attitudes
(Mittal et al., 2014).
Theoretical Approaches
There are several theoretical approaches that have been described as guiding
research in obesity stigma. Among these are a psychobiological approach, Attribution
Theory (Puhl & Brownell, 2003), Social Support Theory (Peterson & Bredow, 2009),
and Socioecological Systems model (Steele et al., 2011), Symbolic Interaction
(Martins & Burbank, 2011; LaBat & DeLong, 1990; Schroeder, 1981), Critical Social
Theory (Martins & Burbank, 2011; Monaghan, 2005), and Critical Interactionism
(Martins & Burbank, 2011).
Psychobiological. The Psychobiological approach could provide nurses with
insight into the mechanisms that control energy intake and expenditure and has been
used by nurses to gain understanding of obesity and to provide education to obese
patients. When one understands the causes that lead to weight gain, they can better
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modify behaviors or the environment to alleviate these causes. This approach
incorporates understanding of the biological effects on weight management, such as
hunger, craving, hedonic sensations, appetite, meals and their constituents,
metabolism, and interactions with brain. Also incorporated is the idea of negative
feedback and that if individuals eat too quickly, they may eat a larger portion before
satiety signals are stimulated. The environment is also important in that nurses and
patients can identify triggers of overeating and reduce or eliminate them.
Understanding metabolism can help identify ways of increasing activity; taking into
account domestic, financial, and environmental factors; which will increase
metabolism and decrease the effect of starvation metabolism. Understanding energy
intake is also important since self-report food intake is often underestimated.
Additional nutrition-focused education could stress the need for more accurate
assessment of energy intake.
Attribution Theory. Attribution Theory deals with beliefs about reasons for
obesity and for weight loss failure. Perception of control, both internal and external, is
an important concept. Internal control assumes that an individual has a greater control
over things, while external control assumes that what happens is out of individual
control. Patients who perceive that they have greater control have greater weight loss
success. In relation to stigmatization, individuals are more likely to stigmatize obese
individuals if they perceive that the cause of the obesity is attributed to controllable
causes rather than uncontrollable causes, such as thyroid disease (DeJong, 1980).
Those who were educated regarding the uncontrollable causes demonstrated less
obesity stigmatization.
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Social Support Theory. Environmental stressors, such as stigmatization, can
affect health. Social Support Theory explains the mediating effect of support on
coping with these stressors. It would be important for nurses to explore with
individuals the extent of social contacts and how much perceived support they have.
Greater support may potentially reduce environmental stress. Support can be in the
form of emotional, informational, instrumental, or appraisal (Peterson & Bredow,
2009).
Socioecological Systems Models. Obesity stigma is a multifactorial issue and
a socioecological model would be useful in determining the individual, family,
nurse/clinician, institutional, and societal factors that may increase or decrease stigma
(Steele et al., 2011). These systems exist as nested structures, moving from the
innermost structure outward. The structures are microsystems, mesosystems,
exosystems, macrosystems, and chronosystems (Bronfenbrenner, 1994). In relation to
obesity stigma, microsystems consist of activities, roles, and relationships experienced
by the obese individual in a given setting with specific physical, social, and symbolic
attributes that permit or inhibit engagement or activity in the immediate environment.
Mesosystems are made up of the linkages and processes between two or more settings
containing the obese individual, such as the relationship between home and a
particular healthcare setting. Exosystems are comprised of linkages and processes that
occur between two or more settings where at least one does not contain the obese
individual, but where events occur that affect them. Macrosystems are comprised of
the overall pattern of micro, meso, and exosystems and could be considered “as a
societal blue-print for a particular culture or subculture” (Bronfenbrenner, 1994, p.
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40). The chronosystem comprises the change over time of characteristics of an
individual and their environment.
Symbolic Interaction. One commonly used theoretical perspective that is
helpful in guiding research in the area of obesity stigma is symbolic interaction.
Following the theoretical framework, the actions of human beings toward things are
based on the meaning that human beings attribute to them. This meaning is the result
of social interaction and can change based on how humans interpret encounters with
others (Blumer, 1969). The world exists separately from the individual, but can only
be interpreted through the use symbols in the process of interaction. Objectivity can
only be approximated because the world is seen through the lens of meaning derived
by many individuals.
There are three main premises that underpin symbolic interaction. The first is
that humans act toward things based on the meaning that they attach to them. The
second is that meaning comes from social interaction. The third premise is that
meanings are assigned and modified through an interpretive process. In relation to
obesity stigma, nurses act toward obese patients based the meaning they attach to
being obese. If nurses attach being lazy or lacking of self-control to obesity, then
biased attitudes may occur. This meaning may arise through interaction with others,
for example medical students interacting with biased residents and physicians, or
through observing the interactions of others in person or through the media. Negative
attitudes toward and interactions with obese individuals can be seen daily through
mass media. The meaning that individuals attach to things is constantly changing.
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This can be seen in studies that described less negative attitudes towards obesity in
individuals who are educated about the uncontrollable causes of obesity.
Within situations, actions arise based on an individual’s own interpretation of
meaning. Stigmatizing actions by nurses towards obese individuals can be explained
using this symbolic interaction process (Burbank & Martins, 2010). Following the
process, nurses have interactions with reference groups that shape their perspectives
regarding obese individuals. These groups can be medical and healthcare
organizations, or society at large. When an obese individual enters into the healthcare
system and interacts with the nurse, negative perspectives fostered by these reference
groups can help define the situation. An important definition of the situation with
nurse-obese patient interactions is the attribution of the causes of obesity and whether
or not the obese individual is in control of their weight gain. The perspectives and
definitions of the nurse drive actions, and obese individuals may receive less care if it
is perceived that the cause of their obesity was within their control. Nurses would feel
justified in their negative perspectives if the obese individual meets the nurse’s
expectations of someone who lacks self-control and is not taking an active role in
reducing their weight by displaying healthcare avoidance behaviors or poor selfesteem/depression, and they would continue to display a negative perspective or bias
towards obese patients.
Critical Social Theory. “Karl Marx believed any understanding of human
societies must begin with the material conditions of human existence, or the
economics of producing the necessities of life. The economic mode of production, due
to its importance, influences other aspects of life, such as political organization,
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ideology, religion and culture: ‘the ideas of the ruling class are in every epoch the
ruling ideas: that is, the class which is the ‘ruling material force’ of society, is at the
same time its ruling intellectual force’” (Marx & Engels, 1994, p. 15). Marxist writers
authors would analyze obesity stigma as a social problem that is directly linked to the
changing mode of production: definitions of obesity stigma and other social problems
are influenced by both the economic and social structures and the core values of
particular modes of production existing in a historical time period. The goal of critical
theory is to create a life free from unnecessary domination (Kim & Holter, 1995).
Habermas described a framework for knowledge specified within three
categories; technical, practical, and emancipatory cognitive interest (Kim & Holter,
1995). Technical interest is achieved through the application of empirical-analytic
science and predictive knowledge is obtained. Understanding in social life is the
orientation of practical interest and is achieved through reflective judgement and
interpretive understanding evident in the historical-hermeneutic sciences. Knowledge
gained through these two categories is not sufficient for full understanding of social
phenomenon. Critical theory goes beyond knowledge gained through empiricalanalytical and historical-hermeneutic sciences by examining power relationships and
creating knowledge oriented toward liberating individuals from domination through a
process of self-enlightenment.
The medicalization of obesity is evidenced by the increase focus on obesity as
a health problem. Much effort and money is spent in the media, weight loss
supplements and programs, and bariatric surgeries. Even with all this effort, stigma
exists because obesity exists as both a medical and a social problem. The stigma of
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obesity could be considered a result of ideological hegemony, or how relationships of
domination and exploitation are embedded within the dominant ideas of society
(Burbank & Martin, 2010). The implicitness of negative attitudes regarding obesity in
healthcare relates how society has internalized the idea that obesity is brought upon
oneself by sloth and overindulgence. Obese patients accessing healthcare are in a
vulnerable position and possess little social power in the nurse/clinician-patient
relationship. Patient encounters, such as the administration of pain medication by a
nurse to a patient, exist on the micro level. Habermas’ communicative action theory,
which emerged from critical theory, would allow linkage of macro
societal/organizational issues to the micro level of the patient encounter.
Critical Interactionism. Another framework that would be useful in the study
of obesity stigma would be critical interactionism. Critical social theory and symbolic
interaction are combined, taking into consideration both downstream and upstream
factors when developing research related to obesity stigma. Martins & Burbank (2011)
compared and contrasted symbolic interaction and critical social theory and described
areas of divergence and synergy (Table 1). Obesity stigma is a complex health issue
and involves the individual and professional groups, healthcare organizations, and
society at large. Both micro and macro approaches need to be incorporated into
interventions designed to alleviate the stigma.
Other theories. Other theoretical approaches included theories on selffulfilling prophesy, attributional ambiguity, stigma-induced identity threat model
(Major & O’Brien, 2005), social consensus model (Puhl & Brownell, 2003). Bos,
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Pryor, Reeder & Stutterheim, (2013) proposed a model of stigma that incorporated
structural, public, and self-stigma and stigma by association.
Measures of Stigma
Negative attitudes exist within stigmatized groups, such as obese individual.
Scales have been used to assess attitudes of obese individuals towards obesity and
obese patients. Friedman et al. (2005) described the use of the Attitudes Toward Obese
Persons Scale, has been used to assess internalization of anti-fat attitudes by obese
patients, and the Beliefs About Obese Persons Scale which assesses beliefs about the
controllability of weight. Wang, Brownell & Wadden (2004) used the Implicit
Association Test (IAT) to investigate the internalization of anti-fat bias among
overweight individuals.
Scales have also been used to assess attitudes of healthcare providers. The Fat
Phobia Scale has been used to assess attitudes toward obese patients (Poon & Tarrent,
2009; Puhl, Wharton & Heuer, 2009; Wolfe, 2010). The Weight Implicit Association
Test (IAT) has been used in studies (Miller et al., 2013; Schwartz et al., 2003) to
assess implicit weight bias. Poon & Tarrent (2009) described the use of the Attitudes
Toward Obese Adult Patients (ATOAP) scale to assess attitudes toward the
management of care of adult obese patients. Measuring the length of visual contact has
also been used to assess attitudes toward obese patients (Persky & Eccleston, 2011).
Many studies described the sole use, or use with a scale, of surveys created by
the researchers for the particular study. Wadden et al. (2000) administered a
questionnaire to women participating at obesity trials and assessed views of weight
control management provided by their primary care physician to compared satisfaction
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scores and association with weight. Foster et al. (2003) conducted a self-reported
survey of physicians’ attitudes about obesity and its treatment that assessed beliefs
about causes of obesity, attributes of obese individuals, beliefs about treatment,
attitudes about weight loss outcomes, and beliefs about the efficacy of obesity
treatment. Brown et al. (2007) used a questionnaire to determine nurses’ practice,
beliefs and attitudes related to obesity management and assessed clinical practice
activities of assessment, advice, support, and referral, beliefs about causes and
consequences of obesity, attitudes toward obese patients or clients, and views on
obesity-related practice development, organizational support and training. Sack et al.
(2009) used a mail survey, adapted from a survey assessing physician attitudes, to
determine the attitudes of physical therapists related to attitudes and management of
obese patients. Forman-Hoffman, Little & Wahls (2006) used a focus group survey to
determine physician barriers to obesity care. Puhl, Wharton & Heuer (2009) created a
survey rating dietary quality, receptivity of treatment recommendations based on
patient profiles in order to assess weight bias among dietetic students.
While relatively easy to administer, a majority of scales used in studies to
assess attitudes toward obese patients are self-reported measures. Study participants
that have concerns related to privacy issues, or how they might personally be
perceived, may have a tendency to under report negative attitudes and over report
positive attitudes. Participants may feel more motivated to bias their responses if they
are expressing socially undesirable behaviors, the questions are of a highly sensitive
nature, the participants have a disposition to give socially desirable answers, or there is
pressure on the participant to give desirable answers.
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Tests that are designed to measure implicit bias that participants may not even
be aware of can alleviate the issues of self-reported measures. The IAT works by
measuring the length of time it takes to categorize a list of words. Pairing of word and
category is easier if the pairing matches the participant’s attitude. Shorter pairings are
attributed to a greater bias, whether positive or negative. Measurement of visual
contact, for example between a healthcare provider and an obese patient, also could be
an unconscious indicator of attitude. For these two methods to be effective,
participants would need to be unaware of the purpose of the measurements. Length of
time it takes to create word-category category pairings, or visual contact time, could
be consciously increased by participants in order not to appear biased. Measurement
equipment must be incorporated into the study and may reduce flexibility of
administration. Paper surveys can be administered anywhere, but these types of
measures may be limited to a particular area that has computers, particular software, or
hardware such as the cameras to measure visual contact.
Surveys created by researchers are highly specific for answering research
questions, yet most often are not tested for validity or reliability. The specificity may
prevent results from being generalizable. On the other hand, if researchers create
questions that are too general, they may not apply to participant as they should. Some
studies have described the use of tested scales in addition to these created surveys to
lend more validity. Surveys, whether self-administered or administered by an
interviewer, are self-reporting, therefore would be subject to the same variances
related to bias as all self-reporting measures.
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The issue of social desirability is an important consideration for all selfreported measures that assess negative or sensitive issues (Krumpal, 2013). The
likelihood of participants telling the truth depends on the perceived risk related to
socially undesirable situations. Participants may fear embarrassment, reactions of an
interviewer, reactions from family and friends present, or retribution such as loss of
job or position. A threat to one’s self concept may occur in answering questions
negatively that may make them look bad. Nurses want to believe that they treat
everyone equally and holistically.
There are several ways to minimize and control for the effect of social
desirability bias (Nederhof, 1985). A self-administered survey may increase the
likelihood of accurate reporting since there is a higher degree of anonymity than if the
survey was administered by an interviewer, although there may be issues with
participants not answering sensitive questions if there is a perceived risk of privacy
breach. Anecdotally, healthcare staff often expressed concern about the privacy of
certain workplace surveys they are asked to take, such as employee satisfaction
surveys, even when they are reassured of the anonymity of the survey. During
interviewer-administered surveys, responders may alter answers based on the
perceived expectations and norms of the interview. For example, a participant would
be less likely to express negative attitudes towards obese individuals if an obese
individual were administering the survey. Bias may also affects interviewers, who may
skip questions they feel uncomfortable asking. To decrease this effect, sensitive
questions could be answered in private and sealed in an envelope before being given
to the interviewer, thereby assuring a higher degree of privacy. Social desirability bias
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may be affected by bystanders, especially if the study participant does not want to
share the information. An example of this would be asking a teen about birth control
in front of their parents, or asking about sexually transmitted disease in front of a
spouse or significant other. Other methods to decrease social desirability bias would to
neutrally word questions to minimize concerns on how answers would be judged, or to
embed sensitive questions among unoffending questions related to the topic of
interest. Another way to minimize bias would be to increase the subjective cost of
misreporting by making the participant believe that there was a method being
employed that would detect misreporting, such as with a lie detector. Social
desirability bias may also be decreased by having the participant act as an informer on
others behavior or attitudes, or by use of someone who knows the target of the study
well. This may work because the participant is not expressing their own beliefs,
attitudes, or behaviors. The informant method may not be effective if there is a
perceived lack of privacy and the participant has fear of repercussions. Another
method includes the randomized response technique where respondents use a
randomizing device, such as a die or coin, to decide which questions they will answer.
The interviewer does not know which question was selected by the participant or their
response. Also, the unmatched count technique could be used. Participants are divided
into two groups, where one group answers a list of non-sensitive questions and the
other answers the same list plus the sensitive questions. Questions that participants
answered “Yes” to would be counted and that number reported to the interviewer.
Another method that may be used to decrease social desirability bias would be
to include a social desirability bias scale within a questionnaire, for example Latner et
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al. (2008) described the use of the Marlowe-Crowne Social Desirability Scale when
measuring for bias toward obese, homosexual, and Muslim individuals. A higher score
on the scale would indicate that a participant may be more likely to under report
negative attitudes. Based on the score, researchers would have the opportunity to
discard the data, adjust the data to account for the bias, or merely recognize that social
desirability bias was a factor within the study and mention it as a limitation.
While the presence of stigma is apparent from studies of obese individuals, the
evidence that stigmatization occurs is less conclusive from studies of healthcare
providers. It is difficult to assess stigma directly from healthcare providers because of
social desirability. Explicit measures of bias are difficult to obtain because subjects
may be reluctant to report negative attitudes. It is possible to indirectly measure the
presence of bias based on measuring the results of the bias. There is an association
between attitude and behavior and the quality of healthcare obese patients receive, for
example less screenings for mammography or Pap smear (Ǿstbyte et al., 2005) or the
absence of weight loss counseling (Tsai & Waden, 2009). Measurement of these
healthcare inequalities would provide a way to identify the presence of stigmatization
while decreasing the effect of social desirability. The issue of privacy is not an issue
since individual healthcare providers are not directly observed or questioned.
There are several pros and cons to doing studies that link healthcare outcomes
to attitude and biases. Biases, such as social desirability, associated with individuals
responding to surveys or interviews would be eliminated. Researchers would be
studying what was documented and not directly studying healthcare providers. Studies
can be done retrospectively potentially giving the researcher access to more data. If
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more data is required, researchers can look back over a broader period. This would be
easier, for example, than trying to recruit more participants to take a survey. There are
less ethical issues related to human subjects, such as ensuring confidentiality and the
need to obtain informed consent, in retrospective record reviews. Such studies would
be measuring actual healthcare outcomes to determine the presence and effect of bias
rather than the results of an experiment. These studies can find associations between
variables. The strength and direction of the relationships can be determined, opening
the way for further study and possibly the determination of causative factors.
The cons of using this type of study are that it would measure an association,
which would not demonstrate that obesity bias is a causal factor in obese patients
receiving less pain medication and that many be other unknown factors may be
affecting pain medication administration besides bias. For example, a patient may
have other health issues that are causing increased pain and results in increased pain
medication administration, or possibly the patient has a higher tolerance for pain, or
other non-medication pain relief are being used. Another con related to doing these
studies retrospectively is that the researcher is relying on the accuracy of the data.
Anecdotally, healthcare providers do not consistently paint a vivid clinical picture
with their documentation. Patient information is often missing, either in error or
because it was never assessed.
Chapter Summary
The concept of stigma and its presence in healthcare was explored. Within
healthcare, obesity is a condition of excess adipose tissue that is stigmatized. There
were few studies found that examined obesity stigma in healthcare, although it has
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been described in relation to other healthcare conditions, such as HIV/AIDS, mental
illness, illicit drug use, epilepsy, and smoking. Obesity stigma has multiple
consequences on healthcare outcomes, both from the patient perspective (e.g.,
decreased self-esteem, healthcare avoidance, etc.) and from a healthcare provider
perspective (fewer referrals for screenings, less time spent with the patient, etc.).
Selection of pain medication administration was based on the findings of the effect the
presence of stigma has on patients receiving less medication. Pain medication
administration has been studied in other stigmatized groups, but has not been studied
in regards to obesity stigma. Pain medication was also selected in order to reduce the
effects of social desirability. After review of multiple theoretical frameworks
associated with the study of stigma, symbolic interaction was selected for this study.
The selection was based on the frameworks alignment with other studies that explored
the meaning individuals held regarding obesity and how it affected attitude.
Following exploration of the concept and theoretical framework, the electronic
medical records related to patient demographics, ordering, and medication
administration were queried. The measurement of dependent and independent
variables is described in Chapter Three. Also described in the next chapter are sample
selection, data analysis, and ethical consideration.
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CHAPTER 3

METHODOLOGY

Treatment of pain has been used as an indicator of bias/stigmatization among
healthcare providers in several studies (Sabin & Greenwald, 2012; Mills et al., 2011;
Burgess et al., 2008; Pletcher et al., 2008), was used in this study. Undertreated postoperative pain is associated with negative healthcare outcomes such as longer hospital
stays, missed or shortened physical therapy sessions, and less ability to ambulate
(Morrison et al., 2003). The relationship of pain treatment to obesity stigma has not
been studied, but as described in the previous section has been studied with other
stigmatized groups.
Research Questions
This quantitative study was designed to answer the following research questions:
1. What is the difference in the total morphine equivalent dose of post-surgical
pain medication administered between normal weight, overweight, and obese
(Class I, II, and III) (World Health Organization, 2014) adult non-bariatric
surgery patients?
2. What is the relationship between pain medication ordered and administered
and the BMI of adult non-bariatric surgery patients?
3. What is the relationship between patients’ BMI and the receipt of post-surgical
pain medication, when accounting for race, gender, age, insurance status,
presence of psychiatric diagnosis, and pain score during hospitalization?
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Design
This study used a retrospective chart review to compare pain treatment among
normal weight, over-weight, and obese patients as a measure of stigma. This design
supported the intent of the study, which is to examine the differences in pain
medication administration based on BMI, the relationships of pain medication
ordering (as entered by the physician) and administration (as documented by the
nurse) between different categories of BMI, and if there is a relationship between BMI
and the amount of pain medication administered.
Sample
The sample was obtained through Information System (IS) query of the
hospital system data warehouse, which contains data from electronic medical records
from three hospitals and has been used by the healthcare system going back to 1993.
The IS analyst employed through the hospital system from where the data was taken
was given specific inclusion and exclusion criteria to extract the data.
Inclusion criteria for the study were adult patients, 18 years of age, who must
have been specifically admitted for a surgical procedure. Patients who were admitted
for bariatric surgery, such as gastric bypass or gastric banding surgery, or were
admitted for medical reasons, but ended up needing surgery, were excluded from the
study. The reason for excluding bariatric surgery was that prior studies have described
that patients who were considered at fault for their obesity were more likely to
generate negative attitudes from study participants than patients that were described as
not being responsible for their obesity, such as in patients with thyroid conditions
(Dejong, 1980). Also, it was possible that nurses working in the specialty of bariatric
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surgery may display less bias related to an increased exposure to obese patients.
Patients who were admitted to the hospital for medical reasons were excluded because
their pain may have been influenced by factors other than surgery. Patients undergoing
bariatric surgery could be considered as taking responsibility for their weight and
taking action, therefore may experience less stigmatization than non-bariatric patients.
Underweight patients were excluded from the study since being underweight may be
associated with other healthcare issues that may impact pain during hospitalization.
Patients who had patient-controlled analgesia ordered in the electronic medical record
by a licensed independent practitioner during the post-operative period were excluded
since they administer their own pain medications and nurses do not.
Certain variables were measured to control for the effects of stigma against
other groups documented in the literature, such as age, race, gender, socioeconomic
status (inferred from insurance status), and psychiatric diagnosis. Also, data was
collected in order to ensure the proper sample. For this study, patients being
hospitalized for other reasons than surgery were excluded. Therefore admission
diagnoses that were surgery-related were necessary. Comparing the date of admission
to the procedure date also helped in sampling to ensure that patients were hospitalized
for surgery and not for other reasons. Patients selected were admitted on the same day
as their surgery. The type of surgical procedure was recorded in order to exclude
bariatric surgery patients. It was also important to identify discharge date. Patients
discharged on the same day were excluded from the study as their surgery would have
minimal interactions with healthcare professionals and pain medication administration
would be strictly limited to the immediate surgical recovery period.

36

Patients were selected from a healthcare system that includes three tertiary,
acute-care hospitals that provide services to Rhode Island, Massachusetts, and
Connecticut. In 2013, 14,884 inpatient surgeries were performed within the system.
The sample was obtained from the historical database system, which files extend back
to 1993. Equal numbers of patients were selected for the normal weight, overweight,
obese I, obese II, and obese III groups, starting with December 31, 2013 and went
back temporally. The final sample consisted of patients who had surgery from January
1, 2013 through December 31, 2013. It was important that the sample be acquired
prior to 2014, since the use of insurance status as an indicator for socioeconomic status
would not have been reliable due to the provision in the Affordable Care Act that all
Americans have access to affordable health insurance options.
A power analysis was performed using SPSS Power 3. The power analysis for
a one-way, fixed effects analysis of variance with 5 levels (normal weight, overweight,
obese class I, obese class II, and obese class III) was performed. The outcome was
that 365 cases per level for a total of 1825 cases were needed. The criterion for
significance (alpha) was set at 0.05. The analysis of variance is non-directional (i.e.
two-tailed) which means that an effect in either direction will be interpreted. For
analysis of variance the effect size (f) was 0.10, which yielded a power of 0.95. A
small effect size for BMI was selected because there were no previous studies
conducted related to BMI and pain medication administration from which effect size
could be inferred. The sample was obtained from patients having surgery during 2013.
Data was de-identified by the Information System (IS) staff prior to delivery for data
analysis and each patient was assigned a unique ID number. Variables in the study
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included age (continuous), gender (categorical), race (categorical), BMI (continuous
and categorical), insurance status (categorical), psychiatric diagnoses during
admission (categorical), pain medication frequency and dose ordered, frequency and
dose of pain medication administration by the nurse, type of drug administered
(narcotic/non-narcotic), and pain score during hospitalization (categorical). After
removal of duplicate cases and cases with no height or weight entry, a random
sampling of BMI categories that contained greater than 365 cases was performed to
achieve the number determined by the power analysis.
Measurement of Dependent Variables
Pain Medication Administration. Data related to pain medication
administered during the first (postoperative day one) and second (postoperative day
two) 24-hour period, for a total of 48 hours after surgery, was collected. This included
the number of times that intravenous narcotics, oral narcotics, and non-narcotics were
administered, as well as the average dose during each 24-hour period. The electronic
medication administration records for the sample were examined to determine which
pain medications were administered and are described in Table 2. Pain medications
were identified from a list extracted from the electronic medical record data based and
if any of these medications that were administered during postoperative day one or day
two the patients were included in the study. Intravenous narcotics of interest during
review of the medical record included morphine, hydromorphone, fentanyl and
meperidine. Non-intravenous narcotics included hydrocodone and oxycodone. Nonnarcotics included acetaminophen, ibuprofen, ketorolac, and diclofenac. Since it is
difficult to do an overall comparison of pain medication due to differing amounts,
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strengths, and doses used between the IV and PO pain medications, narcotic
equivalency used in this study. This method has been used in other studies to facilitate
analysis between different opioid medications (Olson, Hanson, & Michaud, 2003,
Fillingim, Doleys, Edwards, & Lowery, 2003, Allen, et al., 2003). Conversion tables
should be taken as approximations and not as absolute doses. Tables often describe
different conversion and dose calculations and caution is prescribed when using these
in actual clinical practice (Shaheen et al., 2009). The conversion table used for this
study was based on information from GlobalRPh (2015). Narcotic equivalency is an
approximation and compares a given oral or intravenous pain medication dose to the
equivalent dose of oral morphine and approximations used in this study are listed in
Table 3. For example, oxycodone is 1.5 times stronger than oral morphine; therefore
10 mg of oxycodone would be equivalent to approximately 15 mg of oral morphine.
Conversions were done for each medication and added together to determine the total
equivalent dose of oral morphine that each patient received during the first and second
24-hour period after surgery.
Measurement of Independent Variables
Age. Age was measured in years and was selected as a variable because of its
potential effect on the treatment of pain. Older adult patients have been shown to
receive less pain medications than younger patients (Jones, Johnson & McNinch,
1996), therefore it was important to account for age as a potential bias contributing to
the amount of medication received by the patient.
Gender. Gender was measured as male or female. This variable was chosen
because the described differences in the experience of pain between men and women.
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It was necessary to measure gender to account for bias since women were less likely to
be taken seriously, receive adequate treatment for pain, have pain ascribed to
psychiatric causes, and be treated less aggressively.
Race. Race, as valued within the electronic medical record, was described as
White, Black, Asian, and All Other. This variable was selected because other studies,
described within the literature review, have described race as a bias related to
decreased administration of pain medications.
BMI. Body Mass index (BMI) was calculated from recorded height and weight
on admission. BMI is an indicator of body fatness and is calculated by dividing weight
(kg) by height squared (m2). BMI is described by the Centers of Disease Control and
is used to classify individuals into the different weight categories used in this study;
normal (18.5 – 24.9) and overweight (25 – 29.9) (Center for Disease Control and
Prevention, 2015). Definitions of obesity used were broken down by the World Health
Organization as Class I (30 – 34.9), Class II (35 – 39.9), and Class III (≥40) (World
Health Organization, 2014). In this study, the difference in pain medication
administration was compared between normal weight patients and overweight, obese
class I, obese class II, and obese class III patients. Also, the relationship between pain
medication administration and BMI was explored.
Insurance Status. Insurance status included private insurance, Medicare,
Medicaid, Worker’s Compensation, or no insurance categories. This variable was used
as an indicator for socioeconomic status and has been used in multiple studies
(Vijayakumar, et al., 1995, Hong, Baumann, & Boudreaux, 2007) and has been
perceived as a reason for discrimination during healthcare provision. Use of insurance
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status is not an exact measure of socioeconomic status, but status may be inferred. For
example, Medicare is offered to low income individuals.
Psychiatric Diagnosis. Presence of psychiatric diagnosis was positive if any
psychiatric diagnosis listed in the Diagnostic and Statistical Manual of Mental
Disorders exists for the patient during the hospitalization. Mental illness has been
described as a stigmatized condition and therefore it was important to account for it
during this study.
Pain Score. Patients with higher pain scores receive more pain medication, so
it was important to account for pain score to understand if less pain medication is
administered to obese patients. Pain was assessed on a scale of 0-10, with 0 being no
pain and 10 being the worst possible pain ever. This scale is a subjective measure of
pain that is reported to the nurse by the patient. Pain score was entered by the nurse
into the medication administration as ordinal values and were described as mild (1-2),
moderate (3-4), moderate/severe (5-7), and severe (8-10).
Data Analysis
IBM SPSS Statistics 23 was used to analyze data for this research study. Data
for the first research question was analyzed using one-way ANOVA. The dependent
variable was pain medication administration and the independent variable was BMI
category. Pain medication administration was divided into total narcotic equivalency
doses, and the total dose of intravenous and oral narcotic and non-narcotic medications
given during a first and the second day postoperative period. The groups used were the
BMI classifications of normal weight, overweight, and obese class I, obese class II,
and obese class III.
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In addressing the second research question, the number of intravenous and oral
narcotic, and non-narcotic medications ordered and administered were compared
between the five BMI categories. A chi-square test was used to determine if there was
a significant difference between expected (ordered by a licensed independent
practitioner) and observed (administered by the nurse) medication, dose, and
frequencies.
Regression analyses were used to address the third research question. Simple
linear regression was used to determine the relationship between the total morphine
equivalent dose and BMI. Separate analyses were performed for the dose on
postoperative day one and day two to determine if there were any differences in the
relationship between days. Hierarchical linear regression was used to determine the
relationship between dose on postoperative day one, and then the dose on day two, and
BMI after controlling for other factors related to stigma and to the amount of pain each
patient reported. The independent variables for each regression analysis will be BMI
(continuous), race (categorical), gender (categorical), age (continuous), insurance
status (categorical), presence of psychiatric diagnosis (categorical), and average pain
score during hospitalization (categorical). Dummy variables were created for each of
the categorical variables within the regression analysis.
Ethical Considerations
Institutional Review Board approval was obtained from both the hospital
system (Appendix A) and the University of Rhode Island (Appendix B) prior to
conducting this study. Consent was not obtained because this was a retrospective chart
review using de-identified data, posing no more than minimal risk, not affecting the
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rights and welfare of the subjects, and the consent would have been the only
documentation linking the study to the patient. A waiver would not adversely affect
the rights and welfare of the subjects since the study was a retrospective chart review
and all identifiers was removed. The sample size required was large and including
only those samples/records/data for which consent can be obtained would prohibit
conclusions to be drawn or bias the sample such that conclusions would be skewed.
Also, since the potential time period being looked at was ten years, the proportion of
individuals likely to not be able to be contacted due to having relocated or died would
be a significant percentage of the subject population and the research results may not
be meaningful and lose statistical power. All data points were supplied by IS query
and did not contain one of the 18 HIPAA identifiers (U.S. Department of Health and
Human Services, 2012). All data points were supplied by IS query and were deidentified by the Information System (IS) staff prior to delivery for data analysis and
each patient was be assigned an identification (ID) number. Chart review was not
performed remotely. The study did not include the use of investigational drugs,
devices, or psychological interventions. Breach of confidentiality would have been the
only possibility, but was prevented by the use of de-identifying the data. The potential
benefits to research subjects as a result of the study would be the identification of
obesity stigma as a problem as related to post-operative pain medication
administration, creating an impetus to develop interventions aimed toward healthcare
providers, thereby improving outcomes and the quality of care.
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CHAPTER 4

FINDINGS

Data received from IS staff contained 56,384 observations with 2734 unique
cases that spanned 1/1/2013 to 12/31/2013. Multiple observations occurred for
individual cases due to several ICD-9 procedure codes/descriptions being listed for a
single surgical visit. Other than the procedure, data such as age, BMI, race, insurance
status, psychiatric diagnosis, and pain score was identically entered for each duplicate
observation. Procedures were separated out into a different dataset and duplicate
observations were removed. Cases were also removed that contained no height or
weight entries, that had no pain medication documented during the first 48 hours, or
indicated patients on a ventilator. These ventilator patients were removed from the
data set because it was found that they only had intravenous sedation medication, to
maintain a state of unconsciousness, and no pain medication administrations
documented during postoperative day one or two. A total of 1939 cases remained. The
normal, overweight, and obesity class I groups had an excess of cases, from which a
random sampling was performed to achieve 365 cases. With this initial exclusion of
cases, the obesity class II and III groups contained less than 365 cases. The final data
set contained a total of 1704 unique cases, with 21.4% (n=365) normal weight, 21.4%
(n=365) overweight, 21.4% (n=365) obesity class I, 17.1% (n=291) obesity class II,
and 18.7% (n=318) obesity class III individuals. BMI scores ranged from 18.5 to
185.9 (M = 33.1, SD = 11.1). A total of 4203 procedures were performed on the 1704
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patients. The procedures, and their frequencies of being performed, are listed in Table
4. The table lists ICD 9 procedure code descriptions that were performed on more than
one patient. The descriptive statistics for each variable based on BMI are listed in
Table 5.
Dependent Variable
Pain medications documented as given during the first 48 hours after a
procedure were hydromorphone, morphine, fentanyl, meperidine, oxycodone,
ketorolac, acetaminophen, and ibuprofen. A breakdown of frequency can be seen in
Table 6, which displays the pain medication that were listed as being administered, as
well as the number of patients that the medication was given to. Hydromorphone was
a common pain medication during the first 48 hours after surgery and was given to
86.7% (n=1478) of patients during the first 24 hours and 18.2% (n=310) during the
second 24 hours. Descriptive statistics in Table 7 describe the range of doses for each
pain medication administered. These doses were used to calculate the total oral
morphine equivalency dose given. During postoperative day one, the minimum oral
morphine equivalent dose was 1.25 mg and a maximum of 1015 mg (M = 21.2, SD =
35.6). The minimum dose during the postoperative day two was .63 mg and a
maximum of 525 mg (M = 20, SD = 30.5). Table 8 breaks down the descriptive
statistics for total morphine equivalent dose of pain medication by BMI category.
Independent Variables
Age. The age of the study population ranged from 18 to 96 (M = 57.1, SD =
15.9). Descriptive statistics for age within each BMI category are listed in Table 9.
There was a significant difference in the mean age of each group, F (4, 1699) = 32.9, p
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< .0001). Post hoc comparisons (Table 10) using the Tukey HSD test indicated that the
mean age for normal BMI (M = 60.1, SD = 17.9) was significantly greater than the
mean age of the obesity class II (M = 55.2, SD = 15.6) and obesity class III (M = 49.1,
SD = 13.9) groups. The mean age of the overweight group (M = 61, SD = 15.1) was
also significantly greater from the mean age of the obesity class II and III groups. The
mean age of the obesity class III group (M = 49.1, SD = 13.9) was significantly less
than all other groups.
Gender. There was a significant relationship between gender and the five BMI
groups, X2 (4, N= 1704) = 57.3, p <.0001. There were a higher proportion of females
than males in the obesity class III group, which consisted of 30% male (n= 94) and
70% female (n = 224) (Table 11). The obesity class III group had a larger proportion
of females than all the other BMI groups and the overweight group had a larger
proportion of males than all the other BMI groups (Table 12).
Race. There was no relationship between race and the five BMI groups
although overall, a vast majority of cases, 86.9% (n=1481) listed a race of “White”.
The other race categories made up far less of the total population, with 7.2% “Black”,
.3% “Asian”, and 5.5% “All Other”.
Insurance Status. There was a significant relationship between insurance
status and the five BMI groups, X2 (16, N = 1704) = 33, p = .007. There were a higher
proportion of overweight (.22), obesity class I (.23), and obesity class III patients (.2)
with private insurance than the normal BMI group (.19) (Table 13).
Pain Scores. Pain scores were only recorded in 48% (n=824) of cases and
overall frequencies of mild, moderate, moderate/severe, and severe pain are listed in
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Table 14. There was a significant relationship between BMI category and moderate
pain, X2 (4, N = 1704) = 12.6, p = .01. The overweight group had a higher proportion
of reported moderate pain (.26) than the obesity class II group (.13), t (654) = 3.12, p =
.002 (Table 15). There were no other significant differences in moderated pain
between the BMI groups. There was no significant relationship between BMI and mild
pain. No groups had a pain score of moderate/severe or severe recorded.
Research Question
Research Question One. What is the difference in the total morphine
equivalent dose of post-surgical pain medication administered between normal weight,
overweight, and obese (Class I, II, and III) adult non-bariatric surgery patients?
Data for the total postoperative day one and postoperative day two oral
morphine equivalent dose of pain medication contained several extreme outliers which
were removed prior to performing an analysis. These outliers showed dose values
approaching 1015 mg. High doses such as these could harm patients and were most
likely documented in error. Doses greater than 120 mg were removed because many
dosing guidelines recommend a maximum morphine equivalent dose of 120 mg per
day (Franklin et al., 2012, Braden et al., 2010). These high doses may have been
entered in error, or represented patients with high tolerance to narcotics. A significant
difference was not found among the BMI groups related to total doses greater than 120
mg. Descriptive statistics of the study sample after removal of outliers are listed in
Table 16.
Histograms and Q-Q plots for postoperative day one and day two values
demonstrated a positive skew (Figures 1 through 4) and were transformed to
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approximate a normal distribution. A Box-Cox transformation (Osborne, 2010) was
used to obtain normally distributed values for postoperative day one and day two total
morphine equivalent dose. The value of lambda that yielded the smallest value for
mean square residual was 0 for the postoperative day one total morphine equivalent
dose and for the postoperative day two total morphine equivalent dose. Therefore, a
natural logarithmic transformation was performed on the two variables. After
transformation, both variable histograms and Q-Q plots (Figures 5 through 8) better
approximated a normal distribution, although the assumptions of normality and
homogeneity of variance were not met. The Shapiro-Wilks and Levine statistics
demonstrated a significant difference from normality and from homogeneity of
variances and therefore the Brown-Forsythe robust test of means was used determine
the difference in mean between the BMI categories (Brown & Forsythe, 1974).
Games-Howell’s procedure was used for post hoc multiple comparisons due to the
heterogeneity of variances (Keselman & Rogan, 1978). A one-way ANOVA was
performed with the log-transformed total postoperative day one oral morphine
equivalent dose of pain medication dependent variable and the BMI classification
independent variable and there was a significant difference in the mean dose of pain
medication given for each of the BMI categories, F (4, 1468) = 2.72, p = 0.03. GamesHowell’s post hoc test (Table 17) revealed that the geometric mean of the total
postoperative day one oral morphine equivalent dose for overweight individuals was
significantly different (p = .004) and 1.22 times as much as for obesity class III
individuals (95% CI: 1.05 to 1.42 times as much). While there was not a significant
difference with the other groups, there was a downward trend in dose between the
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overweight group and the obesity class I and II groups (Figure 9). The postoperative
dose for the normal BMI group was 1.1 times as much as the obesity class I group, and
1.01 times as much as the obesity class II group. There was not a significant difference
in dose between the normal BMI and all other groups.
A one-way ANOVA was performed with the log-transformed total
postoperative day two oral morphine equivalent dose of pain medication dependent
variable and the BMI classification independent variable. The analysis resulted in no
significant difference in mean dose of pain medication given for each of the five BMI
categories.
Research Question Two. What is the relationship between pain medication
ordered and administered and the BMI of adult non-bariatric surgery patients?
Two-way contingency table analyses were conducted to evaluate if pain
medication ordering and administration were related to BMI. There were two separate
electronic medical record systems used to for ordering and medication administration
and the dose and frequency were not documented in equivalent units between each
system. The medication ordering system used “Units” while the medication
administration system used “mg”. Also, documentation of medication administration
tended to be grouped by the nurse. Multiple doses were grouped into one dose that
would span an eight-hour shift. Because of this the comparison between
dose/frequency ordered and administered to determine if they were related was not
possible.
The two variables were pain medication ordered and administered (Not
Ordered – Not Administered, Not Ordered – Administered, Ordered – Not
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Administered, Ordered – Administered) and BMI (Normal, Overweight, Obesity Class
I, Obesity Class II, Obesity Class III). Pain medication ordered/administered and BMI
were found to be significantly related for hydromorphone, X2 (8, N=1680) = 23.03, p =
.003, morphine, X2 (12, N=1682) = 46.77, p < .0001, meperidine, X2 (8, N=1682) =
29.93, p < .0001, oxycodone, X2 (12, N=1682) = 21.1, p = .05, and acetaminophen, X2
(12, N=1682) = 49.2, p < .0001. There was a borderline significant relationship with
ketorolac, X2 (8, N = 1682) = 15.22, p = .055. A significant relation was not found
between fentanyl ordering/administration and BMI. Follow-up pairwise comparisons
were conducted to evaluate the difference among these proportions. Tables 18 and 19
show the number and proportion results of the crosstabulation. Independent sample ttests were performed for crosstabulation table columns. All t-tests had a significant
result for Levine’s test for equality of variances; therefore the value when equal
variances are not assumed was used. The results of the t-tests are listed in Table 20.
While there were significant differences in proportion found, there were none found
that suggest that the higher BMI groups consistently had smaller proportions for
ordering and administration when compared to the lower BMI groups.
Hydromorphone. In the overweight BMI category, the proportion of
hydromorphone ordered and administered (.96) was greater than the proportion not
ordered and not administered (.006), t (986) = 7.37, p < .0001. Overweight individuals
had a higher proportion of hydromorphone ordered and administered (.23) than the
normal (.21), t (673) = 2.55, p = .01, obesity class I (.21), t (666) = 2.78, p = .006, and
obesity class II (.16), t (481) = 3.62, p < .0001, categories. The obesity class III (.19)
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category had a higher proportion ordered and administered than the obesity class II
(.16) category, t (557) = 2.16, p = .03.
Morphine. The proportion of morphine not ordered and not administered (.74)
was greater than the proportion ordered and administered (.21) in the overweight
category, t (1127) = 4.35, p < .0001. The overweight, t (585) = 5.69, p < .0001, obesity
class I, t (610) = 3.16, p = .002, and obesity class III, t (591) = 4.33, p < .0001,
categories had higher proportions (.25, .22, and .20 respectively) of morphine that was
not ordered and not administered than obesity class II (.14). The proportions of the
overweight (.25), t (720) = 4.34, p < .0001, and obesity class III (.20), t (677) = 2.94, p
= .003, groups for morphine not ordered and not administered were greater than the
proportion of the normal BMI group (.20). The proportion of morphine that was
ordered and administered for the normal BMI category (.25) was greater than in the
overweight (.15), t (710) = 4.05, p < .0001, and the obesity class III (.15), t (680) =
2.77, p = .006, categories.
Meperidine. In the overweight category, there was a higher proportion of
meperidine not ordered and not administered (.98) than ordered and administered
(.01), t (67) = 3.78, p < .0001. The proportion of meperidine not ordered and not
administered was higher among overweight (.22) than obesity class II individuals
(.16), t (427) = 4.31, p < .0001.There was a higher proportion of medication ordered
and administered among obesity class II individuals (.39) than overweight (.07), t
(362) = 3.93, p <.0001, and obesity class I (.14), t (429) = 3.10, p = .002.
Oxycodone. Within the obesity class II category, the proportion of oxycodone
ordered and administered (.24) was greater than medication not ordered and not
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administered (.15), t (282) = 2.80, p = .006.The proportion of medication not ordered
and not administered (.61) was greater than ordered and not administered (.26) among
obesity class III individuals, t (1185) = 2.67, p = .008. The obesity class III group had
a higher proportion (.21) of oxycodone not ordered and not administered than the
obesity class II group (.15), t (600) = 3.06, p = .002.
Ketorolac. Within the obesity class III group, the proportion of ketorolac that
is not ordered and not administered (.84) was greater than the proportion ordered and
administered (.12), t (448) = 2.87, p = .004. The obesity class I group had a greater
proportion of ketorolac ordered and administered (.26) than the obesity class III group
(.13), t (675) = 3.21, p = .001.
Acetaminophen. There is a greater proportion of acetaminophen not ordered
and not administered in the obesity class III category (.33) than the proportion ordered
and administered (.09), t (805) = 4.34, p < .0001. Also within the same BMI category,
the proportion of medication ordered but not administered (.58) was greater than the
proportion ordered and administered (.09), t (816) = 5.99, p < .0001. The overweight
category had a smaller proportion of medication ordered and administered (.27) than
not ordered and not administered (.31), t (590) = 3.34, p = .002, or ordered and not
administered (.42), t (482) = 4.45, p < .0001. The normal (.26), t (646) = 5.08, p <
.0001, overweight (.31), t (631) = 6.35, p < .0001, and obesity class I (.20), t (666) =
3.47, p < .0001, categories had a greater proportion of medication ordered and
administered than the obesity class III category (.09). The overweight category also
had a greater proportion ordered and administered (.31) than the obesity class II
category (.14), t (654) = 3.70, p < .0001. Obesity class III has a greater proportion of
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medication ordered but not administered (.22) than the normal (.21), t (669) = 270, p =
.007, and overweight (.18), t (667) = 4.01, p < .0001, categories.
Research Question Three. What is the relationship between patients’ BMI
and the receipt of post-surgical pain medication, when accounting for race, gender,
age, insurance status, presence of psychiatric diagnosis, and pain score during
hospitalization?
Separate analyses were performed for the total oral morphine equivalent dose
during the first 24-hours (postoperative day 1) and for the second 24 hours
(postoperative day 2) after surgery. Simple linear regression was used to determine the
relationship between the independent variable total postoperative oral morphine
equivalent dose and the dependent variable BMI. Hierarchical multiple regression
analysis was then performed to determine the relationship after controlling for other
factors related to stigma such as age, gender, race, insurance status, psychiatric
diagnosis, and also factors related to the amount of pain each patient reported (pain
score).
Total postoperative day one morphine equivalent dose. Extreme outliers were
found that had cutoff values for Cook’s Distance greater than .0024 (Fox, 1991) and
Leverage values greater than .0023 (Montgomery, Peck & Vining, 2012). In
examining the outliers, BMI was found to be greater than 151 in four of the cases.
While the weight of these patients appeared to be realistic adult weights, 55 kg – 87 kg
(121 – 192 lbs.), the heights were all measured as less than .724 m (2.37 ft.). Most
likely the height values were entered in error and therefore these four values were
removed prior to all regression analyses.
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Simple linear regression assumptions. A simple linear regression was
performed and the assumption of normality of residuals was not met, as shown in
positively skewed histogram (Figure 10) and non-linear P-P plot (Figure 11). Also, the
assumption of homogeneity of variances (homoscedasticity) was not met as seen by a
non-random distribution of points on a scatterplot of studentized residuals against the
predicted value (Figure 12). The variances appeared to increase as a function of the
predicted value.
After performing a natural log transformation of the total postoperative day
one oral morphine equivalent dose, heteroscedasticity was still apparent after
transformation (Figure 13), therefore the independent variable BMI was also
transformed using a natural logarithmic transformation. After transformation of BMI,
the scatterplot of studentized residuals against predicted values (Figure 14)
demonstrated a relatively random display of points that were spread fairly constant
over the range of values of the total postoperative day one oral morphine equivalent
dose provided evidence of homogeneity of variances. Also, the assumption of
normality of residuals was reasonable based on a normally distributed histogram
(Figure 15) and linear P-P plot (Figure 16). The scatterplot of total oral morphine
equivalent dose and BMI indicated that the assumption of linearity was reasonable
with point roughly symmetrical in distribution around the fit line (Figure 17). Figure
14 provided further evidence of linear relationship through a scatterplot of
standardized residuals versus predicted values that demonstrated a random distribution
of points distributed with roughly constant variance around the horizontal line.
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The Durbin-Watson statistic was used to determine independence of errors, d =
1.97, which was between 1.5 and 2.5 (Hutcheson & Sofroniou, 1999) and therefore the
null hypothesis was not rejected and it could be concluded that the errors were not
autocorrelated (Montgomery, Peck & Vining, 2012) and the assumption of
independent errors was been met.
Simple linear regression model. The results of the simple linear regression
suggested a significant relationship between the postoperative day one total oral
morphine equivalent dose and BMI, F (1, 1622) = 5.6, p = .018, and accounted for
approximately .3% of the variance of the equivalent dose (R2 = .003, Adjusted R2 =
.003). The total postoperative day one oral morphine equivalent dose was equal to
3.32 + (-.184)(BMI) mg. Every one percent increase in BMI would result in a .18%
decrease in pain medication administration on postoperative day one, p = .018, 95%
CI [-.337, -.032].
Hierarchical multiple regression. Hierarchical multiple regression was
performed to investigate the relationship between the total postoperative day one oral
morphine equivalent dose and BMI, after controlling for other factors related to
stigma, such as age, gender, race, insurance status, and presence of psychiatric
diagnoses, and also controlling for level of pain. Table 21 contains descriptive
statistics for variables used.
Seventy-four extreme outliers were found that had large cut off values for
Mahalanobis Distance, p < .001. Out of these, twenty-eight cases were highly
influential and had high leverage with Cook’s Distances greater than .0024 and
leverage values greater than .018. No clinical significance of the outliers was readily
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apparent, therefore analyses were run first without removal of outliers and then after
outliers had been removed to examine any differences or patterns. When all outliers
were removed, Asian, Medicaid, and Workers Compensation patients were no longer
accounted for within the sample. The moderate/severe and severe pain independent
variables were not used in any of the regression analyses since there were no cases in
the sample where the presence of moderate/severe or severe pain was reported.
Hierarchical regression assumptions described with outliers intact.
Preliminary analyses were conducted to ensure no violations of the assumptions of
normality of variances, linearity, and homoscedasticity. The assumption of normality
of residuals was reasonable based on a normally distributed histogram (Figure 18) and
linear P-P plot (Figure 19). Evidence of linearity was provided by scatterplots of
standardized residuals versus predicted values that demonstrated a random distribution
of points that were distributed with a roughly constant variance for the total model
(Figure 20) and each of the continuous independent variables, age and BMI, in partial
regression plots (Figures 21 and 22).
Examination of the correlation matrix (Table 22) and the variable inflation
factor (VIF) values for the independent variables suggested that multicollinearity was
not an issue (Montgomery, Peck & Vining, 2012). There was little to low correlation
between the independent variables. VIF values were all less than 10 (1.013 – 1.310).
Most Eigenvalues were well above zero; however the values for moderate pain and
BMI were close to zero (.042 and .002). The Condition Index for moderate pain was
10.66 suggesting a weak to moderate degree a multicollinearity and the value for the
log transformed BMI was above 30 (44.682) suggesting a high degree (Callaghan &
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Chen, 2008). No evidence of multicollinearity was assumed since only one
independent variable had large variance proportions corresponding to each large
condition indices.
The bivariate and partial correlations showed small but significant relations to
total oral morphine equivalent dose and are shown in Table 23. As can be seen, BMI
and age were negatively and significantly correlated, indicating that as BMI and age
increase the amount of pain medication on postoperative day one decreased.
Hierarchical regression model with outliers intact. In the first step of
hierarchical multiple regression, twelve predictors were entered: age, gender, race
(black, Asian, all other), insurance status (Medicare, Medicaid, Worker’s
Compensation, no insurance), presence of psychiatric diagnosis, and level of pain
(mild pain, moderate pain). There were no cases of patients reporting moderate to
moderate/severe pain, therefore these variables were not entered into the regression
equation. The prediction model for the morphine equivalent dose during postoperative
day one was significant, F (12, 1568) = 5.4, p < .001, and accounted for approximately
4% of the variance of the equivalent dose (R2 = .040, Adjusted R2 = .032). After entry
of the natural log transformed BMI at step 2 the total variance explained by the model
as a whole was 4.5% (R2 = .045, Adjusted R2 = .037), F (13, 1567) = 5.7, p < .001. The
introduction of BMI explained an additional .6% of the variance in total dose, after
controlling for age, gender, race (black, Asian, all other), insurance status (Medicare,
Medicaid, Worker’s Compensation, no insurance), presence of psychiatric diagnosis,
and level of pain (mild pain, moderate pain), R2 Change = .006, F (1, 1567) = 9.66, p
= .002. The regression coefficients are listed Table 24 and show that BMI was a
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significant predictor in the model when controlling for the other variables. In the final
model five out of thirteen predictor variables were statistically significant. Patients
with a greater BMI received less postoperative day one pain medication, β = -.25, p =
.002. While keeping all other variables constant, every one percent increase in BMI
would result in a .25% decrease in pain medication administration on postoperative
day one, 95% CI [ -.408, -.092]. Gender was a statistically significant predictor
variable, β = -.142, p = .001, and being female would result in a 14.2% decrease in
pain medication administration, 95% CI [-.223, -.061], keeping all other variables
constant. Age was also a significant predictor of receiving less pain medication, β = .005, p < .0001. While keeping all other variables constant, every one year increase in
age would result in a .5% decrease in pain medication, 95% CI [-.008, -.003] .
Worker’s Compensation patients received 90.8% more pain medication and patients
with a psychiatric diagnosis received 23.2% more, p < .0001, 95% CIs [.553, 1.283]
and p = .001, [.092, .372] respectively when keeping all other variables constant.
Hierarchical regression assumptions described with outliers removed.
Preliminary analyses were conducted to ensure no violations of the assumptions of
normality of variances, linearity, and homoscedasticity. The assumption of normality
of residuals was reasonable based on a normally distributed histogram (Figure 23) and
linear P-P plot (Figure 24). Evidence of linearity was provided by scatterplots of
standardized residuals versus predicted values that demonstrated a random distribution
of points displaying a roughly constant variance around the horizontal line for the total
model (Figure 25) and each of the continuous independent variables, age and BMI, in
partial regression plots (Figures 26 and 27).
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Examination of the correlation matrix (Table 25) and the variable inflation
factor (VIF) values for the independent variables suggested that multicollinearity was
not an issue (Montgomery, Peck & Vining, 2012). There was little to low correlation
between the independent variables. VIF values were all less than 10 (1.013 – 1.291).
Most Eigenvalues were well above zero; however the values for moderate pain and
BMI were close to zero (.041 and .002). The Condition Index for moderate pain was
10.68 suggesting a weak to moderate degree a multicollinearity and the value for the
log transformed BMI was above 30 (44.581) suggesting a high degree (Callaghan &
Chen, 2008). No evidence of multicollinearity was assumed since only one
independent variable had large variance proportions corresponding to each large
condition indices.
The bivariate and partial correlations showed small but significant relations to
total oral morphine equivalent dose and are shown in Table 26. As can be seen, BMI
and age were negatively and significantly correlated, indicating that as BMI and age
increased the amount of pain medication on postoperative day one decreased.
Hierarchical regression model with outliers removed. In the first step of
hierarchical multiple regression, nine predictors were entered: age, gender, race
(black, all other), insurance status (Medicare, no insurance), presence of psychiatric
diagnosis, and level of pain (mild pain, moderate pain). The prediction model for the
morphine equivalent dose during postoperative day one was significant, F (9, 1503) =
3.73, p < .001, and accounted for approximately 2.2% of the variance of the equivalent
dose (R2 = .022, Adjusted R2 = .016). After entry of the natural log transformed BMI at
step 2 the total variance explained by the model as a whole was 2.8% (R2 = .028,
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Adjusted R2 = .021), F (10, 1502) = 4.28, p < .001. Even with the outliers removed, the
introduction of BMI continued to explain an additional .6% of the variance in total
dose, after controlling for age, gender, race (black, all other), insurance status
(Medicare, no insurance), presence of psychiatric diagnosis, and level of pain (mild
pain, moderate pain), R2 Change = .006, F (1, 1502) = 9.09, p = .003. The regression
coefficients are listed Table 27 and show that BMI remained a significant predictor in
the model when controlling for the other variables. In the final model four out of ten
predictor variables were statistically significant. Patients with a greater BMI received
less postoperative day one pain medication, β = -.25, p = .003. While keeping all other
variables constant, every one percent increase in BMI would result in a .25% decrease
in pain medication administration on postoperative day one, 95% CI [ -.409, -.087].
Gender was a statistically significant predictor variable, β = -.142, p = .001, and being
female would result in a 14.2% decrease in pain medication administration, 95% CI [.224, -.059], keeping all other variables constant. Age was also a significant predictor
of receiving less pain medication, β = -.005, p < .0001. While keeping all other
variables constant, every one year increase in age would result in a .5% decrease in
pain medication, 95% CI [-.008, -.002] . Patients with a psychiatric diagnosis received
a 23.7% higher dose, p = .002, 95% CIs [.091, .384] when keeping all other variables
constant.
Total postoperative day two morphine equivalent dose. The four extreme
outliers found with BMI greater than 151 were also removed in examining the
postoperative day two morphine equivalent dose. These were most entered in error and
therefore these four values were removed prior to the analysis. The mean BMI after
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removal of the outliers was 32.8, SD = 9.01, with a minimum BMI of 18.5 and a
maximum of 97.3. Fifty-five cases were highly influential and had high leverage with
Cook’s Distances greater than .0024 and leverage values greater than .018. One
extreme outlier was found that had large cut off values for Mahalanobis Distance, p <
.001. No clinical significance of the outliers was readily apparent, therefore analyses
were run first without removal of outliers and then after outliers had been removed to
examine any differences or patterns. The moderate/severe and severe pain independent
variables were not used in the regression analysis since there were no cases in the
sample where the presence of moderate/severe or severe pain was reported.
Simple linear regression assumptions. A simple linear regression was
performed and the assumption of normality of residuals was not met, as shown in
positively skewed histogram (Figure 28) and non-linear P-P plot (Figure 29). Also, the
assumption of homogeneity of variances was not met as seen by a non-random
distribution of points on a scatterplot of studentized residuals against the predicted
value (Figure 30). The variances appeared to decrease as a function of the predicted
value.
After performing a natural log transformation of the total postoperative day
two oral morphine equivalent dose, heterogeneity of variances was still apparent after
transformation (Figure 31), therefore the independent variable BMI was also
transformed using a natural logarithmic transformation. After transformation of BMI,
the scatterplot of studentized residuals against predicted values (Figured 32)
demonstrated a relatively random display of points that were spread fairly constant
over the range of values of the total postoperative day two oral morphine equivalent
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dose provided evidence of homogeneity of variances. Also, the assumption of
normality of residuals was reasonable based on a normally distributed histogram
(Figure 33) and linear P-P plot (Figure 34). The scatterplot of total oral morphine
equivalent dose and BMI indicated that the assumption of linearity was reasonable
since the points were roughly symmetrical in distribution around the diagonal line
(Figure 35).
The Durbin-Watson statistic was used to determine independence of errors, d =
1.86, which was between 1.5 and 2.5 (Hutcheson & Sofroniou, 1999) and therefore the
null hypothesis was not rejected and it could be concluded that the errors were not
autocorrelated (Montgomery, Peck & Vining, 2012) and the assumption of
independent errors was been met.
Simple linear regression model. The results of the simple linear regression
suggest that there was no significant relationship between the postoperative day two
total oral morphine equivalent dose and BMI, F (1, 519) = 1.93, p = .275. BMI did not
significantly account in the variability of the postoperative day two dose. This
relationship remained insignificant after removal of the fifty-five influential cases with
high leverage and one case with Mahalanobis D2 value p < .001, F (1, 465) = 3.03, p =
.082.
Hierarchical multiple regression. Hierarchical multiple regression was
performed to investigate the relationship total postoperative day two oral morphine
equivalent dose and BMI, after controlling for other factors related to stigma, such as
age, gender, race, insurance status, and presence of psychiatric diagnoses, and also
controlling for level of pain. Table 28 contains descriptive statistics for variables used.
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Hierarchical regression assumptions described with outliers intact.
Preliminary analyses were conducted to ensure no violations of the assumptions of
normality of variances, linearity, and homoscedasticity. The assumption of normality
of residuals was reasonable based on a normally distributed histogram (Figure 36) and
linear P-P plot (Figure 37). Evidence of linearity was provided by scatterplots of
standardized residuals versus predicted values that demonstrated a random distribution
of points that displayed a roughly constant variance around the horizontal line for the
total model (Figure 38) and each of the continuous independent variables, age and
BMI, in partial regression plots (Figures 39 and 40).
Examination of the correlation matrix (Table 29) and the variable inflation
factor (VIF) values for the independent variables suggested that multicollinearity was
not an issue (Montgomery, Peck & Vining, 2012). There was little to low correlation
between all of the independent variables. VIF values were all less than 10 (1.019 –
1.401) Most Eigenvalues were well above zero; however the values for moderate pain
and BMI were close to zero (.039 and .002). The Condition Index for moderate pain
was 10.66 suggesting a weak to moderate degree a multicollinearity and the value for
the log transformed BMI was above 30 (44.194) suggesting a high degree (Callaghan
& Chen, 2008), but multicollinearity was not assumed since only one independent
variable had large variance proportions corresponding to the large moderate pain and
BMI condition indices.
The bivariate and partial correlations showed no significant relations among
the continuous independent variables to total oral morphine equivalent dose and are
shown in Table 30.
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Hierarchical regression model with outliers intact. In the first step of
hierarchical multiple regression, twelve predictors were entered: age, gender, race
(black, Asian, all other), insurance status (Medicare, Medicaid, Worker’s
Compensation, no insurance), presence of psychiatric diagnosis, and level of pain
(mild pain, moderate pain). There were no cases of patients reporting moderate to
moderate/severe pain, therefore these variables were not entered into the regression
equation. The prediction model for the morphine equivalent dose during postoperative
day two was significant, F (12, 498) = 2.32, p = .007, and accounted for
approximately 5.3% of the variance of the equivalent dose (R2 = .053, Adjusted R2 =
.030). After entry of the natural log transformed BMI at step 2 the total variance
explained by the model as a whole remained 5.3% (R2 = .053, Adjusted R2 = .029), F
(13, 497) = 2.16, p = .01. The introduction of BMI did not add significantly to the
model. The addition explained an additional .1% of the variance in total dose, after
controlling for age, gender, race (black, Asian, all other), insurance status (Medicare,
Medicaid, Worker’s Compensation, no insurance), presence of psychiatric diagnosis,
and level of pain (mild pain, moderate pain), R2 Change = .001, F (1, 497) = .263, p =
.608. The regression coefficients are listed Table 31 and show that BMI was a not a
significant predictor in the model when controlling for the other variables. In the final
model two out of thirteen predictor variables were statistically significant. Gender was
a statistically significant predictor variable, β = -.219, p = .009, and being female
would result in a 21.9% decrease in pain medication administration, 95% CI [-.384, .054], keeping all other variables constant. Worker’s Compensation patients received
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83.4% more pain medication, 95% CIs [.553, 1.283] when keeping all other variables
constant.
Hierarchical regression assumptions described with outliers removed.
Preliminary analyses were conducted to ensure no violations of the assumptions of
normality of variances, linearity, and homoscedasticity. The assumption of normality
of residuals was reasonable based on a normally distributed histogram (Figure 41) and
linear P-P plot (Figure 42). Evidence of linearity was provided by scatterplots of
standardized residuals versus predicted values that demonstrated a random distribution
of points and a roughly constant variance around the horizontal line for the total model
(Figure 43) and each of the continuous independent variables, age and BMI, in partial
regression plots (Figures 44 and 45).
Examination of the correlation matrix (Table 32) and the VIF values for the
independent variables suggested that multicollinearity was not an issue (Montgomery,
Peck & Vining, 2012). There was little to low correlation between the independent
variables and VIF values were all less than 10 (1.012 – 1.404) Most Eigenvalues were
well above zero; however the values for moderate pain and BMI were close to zero
(.038 and .002). The Condition Index for moderate pain was 11.2 suggesting a weak to
moderate degree a multicollinearity and the value for the log transformed BMI was
above 30 (50.22) suggesting a high degree (Callaghan & Chen, 2008). No evidence of
multicollinearity was assumed since only one independent variable had large variance
proportions corresponding to each large condition indices.
The bivariate and partial correlations showed small but significant relations to
total oral morphine equivalent dose and are shown in Table 33. As can be seen, gender
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was negatively and significantly correlated, indicating that when the gender was
female, the amount of pain medication on postoperative day one decreased. There was
a positive and significant correlation between the dose of pain medication and
Worker’s Compensation. Patients with Worker’s Compensation tended to receive a
higher dose of pain medication. BMI was not significantly correlated with the dose of
pain medication.
Hierarchical regression model with outliers removed. In the first step of
hierarchical multiple regression, twelve predictors were entered: age, gender, race
(black, Asian, all other), insurance status (Medicare, Medicaid, Worker’s
Compensation, no insurance), presence of psychiatric diagnosis, and level of pain
(mild pain, moderate pain). There were no cases of patients reporting moderate to
moderate/severe pain, therefore these variables were not entered into the regression
equation. The prediction model for the morphine equivalent dose during postoperative
day two was significant, F (12, 444) = 1.66, p = .075, and accounted for
approximately 4.3% of the variance of the equivalent dose (R2 = .043, Adjusted R2 =
.017). After entry of the natural log transformed BMI at step 2 the model remained
significant, F (13, 443) = 1.65, p = .068, and the total variance explained by the model
as a whole 4.6% (R2 = .046, Adjusted R2 = .018). The introduction of BMI did not add
significantly to the model. The addition explained an additional .4% of the variance in
total dose, after controlling for age, gender, race (black, Asian, all other), insurance
status (Medicare, Medicaid, Worker’s Compensation, no insurance), presence of
psychiatric diagnosis, and level of pain (mild pain, moderate pain), R2 Change = .004,
F (1, 443) = 1.71, p = .192. The regression coefficients are listed Table 34 and show
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that BMI was not a significant predictor in the model when controlling for the other
variables. In the final model two out of thirteen predictor variables were statistically
significant. Gender was a statistically significant predictor variable, β = -.190, p =
.025, and being female would result in a 19% decrease in pain medication
administration, 95% CI [-.356, -.024], keeping all other variables constant. Worker’s
Compensation patients received 73.8% more pain medication, 95% CIs [.074, 1.402]
when keeping all other variables constant.
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CHAPTER 5

DISCUSSION AND CONCLUSIONS

Obesity is a stigmatized condition and since other stigmatized groups have
been shown to receive less pain medication it was hypothesized that obese individuals
would receive less pain medication postoperatively than lower BMI groups. This study
set out to explore ordering and administration practices of pain medication between
normal, overweight, obesity class I, obesity class II, and obesity class II groups and
has identified differences and relationships between groups. The literature on patient
outcomes related to pain and obesity stigma is non-existent. The intention of this study
was to begin exploration into obesity as a stigmatized condition that affects pain
management and answer three questions:
1. What is the difference in the total morphine equivalent dose of postsurgical pain medication administered between normal weight, overweight,
and obese (Class I, II, and III) adult non-bariatric surgery patients?
2. What is the relationship between pain medication ordered and administered
and the BMI of adult non-bariatric surgery patients?
3. What is the relationship between patients’ BMI the receipt of post-surgical
pain medication, when accounting for race, gender, age, insurance status,
presence of psychiatric diagnosis, and pain score during hospitalization.
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Independent Variables
There were differences in age (Tables 9 and 10), gender (Tables 11 and 12),
insurance status (Table 13), and pain score (Tables 14 and 15). The differences in age,
with the mean age decreasing as BMI increased, was most likely due to the heaviest
patients dying earlier than the lighter patients since there numerous diseases associated
with an increased weight (e.g., heart disease, cancer, etc) (Peeters et al., 2003).
Another explanation for the decreasing age could have been due to the heavier patients
needing to be hospitalized and needing surgery at an earlier age due to the presence of
obesity-related diseases. Women are more susceptible to becoming obese and there are
approximate three obese women for every two obese men (Wells, Marphatia, Cole &
McCoy, 2012) and the higher proportion of obese females supports this. A greater
proportion of private insurance in the overweight and obese groups compared to the
normal BMI group may be explained by the sampling and types of surgeries
performed. The sample included patients who were admitted on the same day as their
surgeries and a vast majority of these surgeries are planned and scheduled ahead of
time through the surgeons’ offices. Patients who schedule elective surgeries may be
more likely to have private insurance. Also, another explanation could have been that
the heavier patients were also younger and therefore may still have been employed and
receiving private insurance through their employer. The findings related to pain scores
were important since it showed that the obese III group was not complaining of
moderate pain more or less than the normal, obesity class I, and obesity class II groups
and there were no differences in mild pain between all groups. This variable may not
have added much understanding of stigma since there were no moderate/severe or
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severe pain scores recorded. In 2013, the healthcare system had multiple locations for
which pain score may have been documented, including a paper record. One
explanation for the low percentage of pain scores recorded in the medication
administration system may have been that they were documented on paper. Also, it is
possible that the pain scores recorded in the medication administration system could
have been pain scores recorded after the administration of medication. They may have
only been reflecting the improvement of pain, but it was not possible to determine this
from the data set.
Research Question One
While there was a general downward trend of the mean dose of pain
medication, the overweight, obesity class I, II, and III groups did not receive
significantly less than the normal BMI group. It cannot be inferred that patients with
high BMI received less pain medication (i.e., are stigmatized) than normal BMI
patients. Taking into consideration the 37.3% of adults in Rhode Island (28.3%
nationally) who are overweight and the 27.3% (28.3% nationally) who are obese,
higher weights are becoming the norm. (Centers for Disease Control and Prevention,
2015). Studies have described a tendency to perceive higher weights as normal
(Tschamler, Conn, Cook & Halterman, 2009, De La O et al., 2009, Johnson, Cooke,
Croker & Wardle, 2008). In a study examining perceived discrimination, Carr &
Friedmnan (2005) found no difference between normal and overweight groups. In
addition to using a normal BMI population as a comparison group, comparing
overweight patients to the heaviest patients may also be appropriate. Examining the
results from this perspective, there was a significant difference in the dose of pain
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medication given on postoperative day one between the overweight and obesity class
III groups. The overweight group received more pain medication than the obesity class
I and II groups and significantly more than the obesity class III group. Since the
heaviest patients received less pain medication, stigmatization associated with patient
weight may be present. This receipt of less pain medication by the heaviest groups
may be as a result to negative attitudes from the healthcare providers. This would fit
with Lewis & Van Puymbroeck’s (2008) description of discriminatory acts tied to
negative attitudes.
Research Question Two
Comparing overall pain medication ordering and administration practices
among the five BMI categories was inconclusive in demonstrating clear patterns and
differences in proportion between groups. A greater proportion of acetaminophen was
ordered and not administered to obesity class III patients than normal and overweight
BMI patients, which does support the literature related to less pain medication
administration for stigmatized groups, although this may not be a significant finding
since acetaminophen is usually not the primary choice for postoperative pain
medication. Another interesting finding was that there were a proportion of patients
that were administered hydromorphone, morphine, fentanyl, meperidine, oxycodone,
and acetaminophen without the medication having been ordered by a licensed
independent practitioner. It is possible that these drugs may have been administered to
patients as a result of a verbal order that never was entered into the electronic medical
record. Finding an overall relationship among all medications that supported bias
towards higher weight patients was difficult. This may have been due to other factors,
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such as most pain medications are ordered on an “as needed” basis and clinicians have
different interpretations of the intent of these orders (Gordon et al., 2008). Also, the
“habitus” may have differed between postoperative units (Lauzon Clabo, 2008). For
example, some units may treat pain while taking into consideration the individual
needs of the patient, while other units may have treated pain more from the standpoint
of pain associated with a particular type of surgical procedure and not weighted the
patient’s experience as heavily. In future research this question needs to be approached
differently, taking dose into consideration. Other factors besides stigma may also need
to be accounted for when examining ordering and administration practices, such as
level of knowledge regarding pain management or opioid safety and addiction. Also,
since most patients have postoperative medications ordered, it may be more
illuminating to examine the physician ordering practices in relation to recommended
guidelines. Physician attitudes toward obese patients have been shown to affect
prescribing patterns (Huizinga, 2012). Further study is needed to determine if ordering
of pain medication is affected by weight.
Research Question Three
There was a significant relationship found between the total postoperative oral
morphine equivalent dose administered on postoperative day one and BMI, while
controlling for other variables related to other stigmatizing conditions. BMI was the
highest weighted predictor. It has been described that obese patients do not need any
more pain medication that normal BMI patients (Patanwala, Holmes & Erstad, 2014),
but this study found that there was a decrease in pain medication dose as BMI
increased. Age was not as weighted a predictor of receiving less pain medication as
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being black or being female, although it could be considered comparable to these
when accounting for the scale. For example, the gender and racial category could only
increase by a unit of one, since the variables were measured as either being black or
not and being male or being female. There was a larger range of possible increases
with age. Worker’s Compensation patients and patients with a psychiatric diagnosis
received a much greater proportion of pain medication dose, 90.8% and 23.2% more
respectively. This finding may have been due to the characteristics of each group, such
as being more demanding for pain medication or having surgical procedures that may
be inherently more painful, but it may have also been due to the low amount of cases
within the groups. There were only 19 Worker’s Compensation patients and 149
patients with a psychiatric diagnosis in the sample. The findings of this study support
the hypothesis that BMI is related to the treatment of pain and that increased weight,
i.e. obesity, contributed to a lesser dose of pain medication administered. Past studies
have linked stigma of race, gender, and age to pain medication administration
practices that resulted in the receipt of less pain medication. While there was a low
percent of the variance in total morphine equivalent dose explained by regression
model (.6%) and a very low correlation between independent and dependent variables,
this was understandable when taking into account the many factors in healthcare and
human behavior which may impact the dose of medication received by the patient.
BMI and the other independent variables were only a small portion of what may
account for the dose of pain medication. The purpose of this study was to understand
the relationship between the variables and small but significant relationships were
found. These findings are supported by past research and there was persuasive initial
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evidence that obesity, also a stigmatized attribute, may have impacted the
administration of medications for pain when taking into account other factors related
to stigmatization.
Limitations
There were several limitations that affected this study. After removal of
duplicate cases and cases with missing information, the obesity class II and III groups
contained fewer cases than the other groups, 291 and 318 respectively, and therefore
those groups did not achieve the needed cases to yield a power of .95 and the
possibility of incorrectly rejecting the null hypothesis is higher. Also, the number of
patients receiving pain medication on postoperative day two was less than on day one.
There were only 525 patients for which pain medication was documented on
postoperative day two. If interested in determining if any differences total dose of pain
medication continued past postoperative day one then ensuring that there are more
patients who received pain medication on day two are included in the sample would
increase the probability of finding a significant result.
Another limitation was that data was not collected through a random sample,
but through IS query based on criteria. Sampling from three different hospitals did
strengthen the generalizability of this study; however non-random sampling decreases
the ability of the results to be generalized to a larger or different population. While
differences in independent variables could be explained from the literature, some of
these differences may have introduced sampling bias since the sample was not equally
balanced. Also there was an unequal sample size among the five categories. The
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obesity class II and III groups had fewer cases than the other groups due to exclusion
and removal.
The use of BMI was another limitation. BMI is a measure of weight status that
depends upon a patient’s height and weight to determine a value that places them
within a category that can be used to flag the patient as being under weight, normal
weight, overweight, or obese. A patient may have a very low percentage of body fat,
but be considered obese by measurement if they have a large muscle mass combined
with a shorter stature. Some patients falling into this category may be present in the
sample, but it was impossible to determine this based on the data acquired.
Another limitation was that pain score was recorded in the electronic medical
record for only 48% of the cases. This may have been due to the multiple locations
that nurses document pain, including both paper and electronic records. Also, the pain
scores that were recorded in the medication administration system were categorical,
grouping pain scores into categories, and not continuous. This would not precisely
capture pain scores reported by each patient. There was not an adequate representation
of each patient’s pain as there would be if an integrated electronic medical record
existed.
Finally, the categorization of race within the electronic medical record was
suspect. There were a large proportion of patients classified as “White” within the
study. Many of these patients had languages other than English listed as a primary
language. “White” therefore was not an accurate representation of race since it
appeared that Hispanic, as well as other race designations, were most likely included
in the variable category.
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Symbolic Interaction
The actions that healthcare providers take toward their patients are based on
the meaning that they attribute to them or their conditions. If there is a negative
meaning attributed, then care of the patient may be adversely affected. This was
described in past studies examined the impact of racial bias on pain medication
administration. This study supports the premise that meaning is reflected in action
since there was a difference in the amount of pain medication a patient received based
on their BMI. As BMI increased, the amount of pain medication administered
decreased. Stigma related to obesity may have been a factor. Since a difference was
found, further research that incorporates measures of attitude or bias is important in
determining the presence and extent of obesity stigma, and the meanings that are held
by healthcare providers. The third premise of symbolic interaction, that meanings are
assigned and modified through an interpretive process, will be important in developing
interventional studies designed to modify meanings that are attached to obesity. The
decision to use symbolic interaction, and not critical theory or critical interactionism,
as a framework to guide meaning and assumptions was based on the micro-level view
of the research. Pain medication administration was viewed at the individual
perspective. The assumption that nurses derive meaning from obesity which creates
stigma and negatively affects healthcare outcomes, i.e. pain medication administration,
was central in this study. Pain medication administration had never been examined in
relation to obesity stigma; therefore it was important to first understand if there were
any differences in administration based on BMI. Future research could incorporate
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critical social theory, using a critical interactionist perspective to address the
individual/micro level as well as the organizational/societal/macro level.
Implications for Research
The findings of this study did show that there was a difference in the receipt of
pain medication depending on BMI, and that as BMI increased the dose of medication
decreased. Only an implied association of these findings to stigmatization can be made
and more research is needed to strengthen the evidence. Mixed-methods research that
combines the measurement of outcomes with a tool to measure attitudes and biases
would be valuable in strengthening the theory that obesity stigma negatively affects
the treatment of pain. Also, expanding the study to include different patient or
healthcare facility types would increase the generalizability of any findings.
Incorporation of qualitative research examining the meaning of obesity and its effect
on pain control would contribute to the usefulness of symbolic interaction as an
explanatory theory regarding the under treatment of pain in obese patients. Further
research using the theory would be useful in developing interventional studies. Studies
that use “priming” as an intervention may be effective in reducing stigma/stereotyping
that impacts patient care (Burgess, van Ryn, Crowley-Matoka & Malat, 2006).
“Priming” can be described as providing the subject(s) of interest with information
that generates a specific attitude desirable by the researcher.
Implications for Education
Prior research involving students has described the presence of weight bias.
Biases may continue on into clinical practice, maintaining an environment where
stigma is perpetuated. Educational interventions aimed at students would improve
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attitudes, decrease bias, and ultimately may improve pain management in obese
patients. It would be important to incorporate education designed to decrease obesity
stigma into nursing curriculum. Continuing education for clinicians may also decrease
obesity stigmatization. Bariatric sensitivity training has been used successfully in
decreasing weight bias in nurses (Falker & Sledge, 2001) and may have a positive
impact on the treatment of pain.
Implications for Practice
Negative attitudes and bias toward obese patients have been described as often
being implicit among healthcare providers. They are unaware of the impact of
negative beliefs on decision making and care provided. Other studies have described
individuals as being less likely to have negative attitudes toward obesity if education
was provided on the uncontrollable causes of obesity (DeJong, 1980). Interventions
designed to change attitudes may also have a positive impact on pain management.
This study begins to shed light on the effect of BMI on nurses’ attitudes and behaviors
related to the treatment of pain. Reducing bias would improve the quality of care. Pain
management is of crucial importance to clinicians, especially due to quality of care
and interest by government and accrediting agencies. Aspects of pain management are
often included by hospitals as quality improvement measures. The Centers for
Medicare and Medicaid Services include pain as an indicator in its Hospital Consumer
Assessment of Healthcare Providers and Systems survey (CMS.gov, 2014). Pain
management is also a concern of The Joint Commission (The Joint Commission,
2015). The results of this study indicate that there are differences in the treatment of
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pain based on BMI, which if improved would also improve survey results and the
quality indicators.
Healthcare, caring for our patients, and providing care are examples of
terms/phrases that healthcare providers use when describing what they do as a
profession. Caring and stigma should be considered mutually exclusive concepts. The
meaning providers attach to being obese affects their thought and actions. By allowing
stigma, either consciously or unconsciously, to have an impact on care we are setting
up situations of inequality. All patients deserve to receive the very best quality of care
regardless of weight.

“Our prime purpose in this life is to help others. And if you can’t help them, at
least don’t hurt them.” Dalai Lama.
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Table 2.
Post-operative pain medications
Medication
Morphine

Classification
Indication
Therapeutic:
Severe pain
opioid analgesics

Dosage Frequency
Intramuscular, Intravenous, Subcutaneous
(Adults ≥50 kg):
Usual starting dose for moderate to severe pain
in opioid-naive patients—4–10 mg every 3–4
hours.
For very severe pain additional smaller doses
may be given every 3–4 hours.

Hydromorphone

Therapeutic:
Moderate to severe pain (alone Intravenous, Intramuscular, Subcutaneous
opioid analgesics and in combination with
(Adults ≥50 kg):
nonopioid analgesics)
1.5 mg q 3–4 hr as needed initially; may be ↑.

Hydrocodone

Therapeutic:
Used mainly in combination
opioid analgesics with nonopioid analgesics
(acetaminophen/ibuprofen) in
the management of moderate to
severe pain.

Fentanyl Citrate

Therapeutic:
Preoperative and postoperative analgesia.
Intramuscular, Intravenous (Adults and
opioid analgesics
Children > 12 yr):
50–100 mcg; may repeat in 1–2 hr.

Meperidine

Therapeutic:
Moderate or severe pain (alone Oral, Intramuscular, Subcutaneous (Adults):
opioid analgesics or with nonopioid agents).
Analgesia—50 mg q 3-4 hr; may be ↑ as
needed (not to exceed 600 mg/24 hr).

Oxycodone

Therapeutic:
Moderate to severe pain
opioid analgesics

Oral (Adults ≥50 kg): 5–10 mg q 3–4 hr
initially, as needed.

Acetaminophen

Therapeutic:
Oral, Rectal: Treatment of:
antipyretics, non- Mild pain.
opioid analgesics Intravenous: Treatment of: Mild
to moderate pain, Moderate to
severe pain with opioid
analgesics.

Oral (Adults and Children >12 yr): 325–650
mg q 4–6 hr or 1 g 3–4 times daily or 1300 mg
q 8 hr (not to exceed 4 g or 2.5 g/24 hr in
patients with hepatic/renal impairment).
Intravenous (Adults and Children ≥13 yr and
≥50 kg): 1000 mg q 6 hr or 650 mg q 4 hr (not
to exceed 4 g/day or less than 4 hr dosing
interval).

Source: Nursing Reference Center, (2015).
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Oral (Adults):
Analgesic—2.5–10 mg q 3–6 hr as needed; if
using combination products, acetaminophen
dosage should not exceed 4 g/day and should
not exceed 5 tablets/day of ibuprofencontaining products

Table 2.
Post-operative pain medications (cont’d).
Medication
Ibuprophen

Classification
Therapeutic:
antipyretics,
antirheumatics,
non-opioid
analgesics,
nonsteroidal antiinflammatory
agents

Indication
Oral, Intravenous: Treatment
of: Mild to moderate pain,
Fever. Oral: Treatment of:
Inflammatory disorders
including rheumatoid arthritis
(including juvenile) and
osteoarthritis, Dysmenorrhea.
Intravenous: Moderate to
severe pain with opioid
analgesics.

Dosage Frequency
Oral (Adults): Anti-inflammatory—400–800
mg 3–4 times daily (not to exceed 3200
mg/day).
Analgesic/antidysmenorrheal/antipyretic—200–
400 mg q 4–6 hr (not to exceed 1200
mg/day).
Intravenous (Adults): Analgesic—400–800 mg
q 6 hr as needed (not to exceed 3200 mg/day);
Antipyretic—400 mg initially, then 400 mg q
4–6 hr or 100–200 mg q 4 hr as needed (not
to exceed 3200 mg/day).

Ketorolac

Therapeutic:
Short-term management of pain Intravenous (Adults <65 yr): Single dose—30
nonsteroidal anti- (not to exceed 5 days total for mg. Multiple dosing—30 mg q 6 hr (not to
inflammatory
all routes combined).
exceed 120 mg/day).
agents, nonIntravenous (Adults ≥65 yr, <50 kg, or with
opioid analgesics
renal impairment): Single dose—15 mg.
Multiple dosing—15 mg q 6 hr (not to exceed
60 mg/day).

Diclofenac

Therapeutic: nonopioid analgesics,
nonsteroidal antiinflammatory
agents

Oral: Management of
Oral (Adults): Rheumatoid arthritis (delayedinflammatory disorders
release [enteric-coated] tablets)—50 mg 3–4
including: Rheumatoid arthritis, times daily or 75 mg twice daily (usual
Osteoarthritis, Ankylosing
maintenance dose 25 mg 3 times daily).
spondylitis. Primary
Rheumatoid arthritis (extended-release
dysmenorrhea. Relief of mild to tablets)—100 mg once daily; if unsatisfactory
moderate pain. Acute treatment response, dose may be ↑ to 100 mg twice
of migraines (powder for oral daily. Osteoarthritis (delayed-release [entericsolution).
coated] tablets)—50 mg 2–3 times daily or 75
mg twice daily. Osteoarthritis (extendedrelease tablets)—100 mg once daily.
Ankylosing spondylitis (delayed-release
[enteric-coated] tablets)—25 mg 4 times daily,
with an additional 25 mg given at bedtime, if
necessary.

Source: Nursing Reference Center, (2015).
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Table 3.
Narcotics and their Narcotic Equivalency to Oral Morphine

Equianalgesia

(morphine, PO)

Analgesic

Strength
(relative)

Morphine (IV/IM)

3

Equivalent Dose
(10 mg)
3.33 mg

Codeine

1⁄10

100 mg

Meperidine
Hydrocodone
Oxycodone
Hydromorphone
Fentanyl

1⁄3
1
1.5
5
50–100

28 mg
10 mg
6.67 mg
2 mg
0.1–0.2 mg

Ketorolac

30

10 mg

Source: GlobalRPh (2015).
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Table 4.
Procedures performed on more than one patient.
Procedure
LAPAROSCOPIC GASTROENTEROSTOMY
FUSION OR REFUSION OF 2-3 VERTEBRAE
RADICAL PROSTATECTOMY
LAPAROSCOPIC CHOLECYSTECTOMY
OTHER LYSIS OF PERITONEAL ADHESIONS
REGIONAL LYMPH NODE EXCISION
IV DISC EXCISION
OTHER PARTIAL RESECTION OF SMALL INTESTINE
PROCEDURE ON SINGLE VESSEL
EXCISION OF OTHER BONE FOR GRAFT, EXCEPT FACIAL BONES
LUMBAR AND LUMBOSACRAL FUSION OF THE POSTERIOR COLUMN, POSTERIOR
NEPHROURETERECTOMY
LAPAROSCOPIC LYSIS OF PERITONEAL ADHESIONS
LAPAROSCOPIC APPENDECTOMY
LAPAROSCOPIC RIGHT HEMICOLECTOMY
ENDARTERECTOMY OF OTHER VESSELS OF HEAD AND NECK
OTHER OPEN INCISIONAL HERNIA REPAIR WITH GRAFT OR PROSTHESIS
INSERTION OF INTERBODY SPINAL FUSION DEVICE
SIMPLE EXCISION OF OTHER LYMPHATIC STRUCTURE
OTHER CERVICAL FUSION OF THE ANTERIOR COLUMN, ANTERIOR TECHNIQUE
PARTIAL NEPHRECTOMY
OTHER EXPLORATION AND DECOMPRESSION OF SPINAL CANAL
CLOSURE OF STOMA OF SMALL INTESTINE
LAPAROSCOPIC REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH
LAPAROSCOPIC SIGMOIDECTOMY
THORACOSCOPIC EXCISION OF LESION OR TISSUE OF LUNG
FIBER-OPTIC BRONCHOSCOPY
OTHER OPERATIONS ON BONE MARROW
THORACOSCOPIC LOBECTOMY OF LUNG
INTRAOPERATIVE CHOLANGIOGRAM
EXTERIORIZATION OF SMALL INTESTINE
LAPAROSCOPIC PROCEDURES FOR CREATION OF ESOPHAGOGASTRIC SPHINCTERIC
OTHER INCISION WITH DRAINAGE OF SKIN AND SUBCUTANEOUS TISSUE
COMPLETE THYROIDECTOMY
INSERTION OF INTERCOSTAL CATHETER FOR DRAINAGE
OTHER RESECTION OF RECTUM
OTHER ANTERIOR RESECTION OF RECTUM
ENDARTERECTOMY OF LOWER LIMB ARTERIES
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Count
106
100
89
81
71
70
68
65
60
59
55
53
52
51
49
47
47
45
44
41
41
40
38
37
35
33
32
32
30
28
27
27
27
26
26
26
25
23

Table 4.
Procedures performed on more than one patient.
Procedure
Count
OTHER (PERIPHERAL) VASCULAR SHUNT OR BYPASS
23
OTHER BRONCHOSCOPY
23
PERCUT NEPHROST-NO FRAG
23
PROCEDURE ON TWO VESSELS
23
RETROGRADE PYELOGRAM
23
ANGIOPLASTY OF OTHER NON-CORONARY VESSEL(S)
22
OTHER LOBECTOMY OF LUNG
22
BIOPSY OF LYMPHATIC STRUCTURE
21
LAPAROSCOPIC VERTICAL (SLEEVE) GASTRECTOMY
21
LARGE-TO-LARGE INTESTINAL ANASTOMOSIS
21
ARTERIOGRAPHY OF FEMORAL AND OTHER LOWER EXTREMITY ARTERIES
20
FORMATION OF CUTANEOUS URETERO-ILEOSTOMY
20
CLOSURE OF STOMA OF LARGE INTESTINE
19
OTHER LAPAROSCOPIC UMBILICAL HERNIORRHAPHY
19
RADICAL CYSTECTOMY
19
OTHER ENDOSCOPY OF SMALL INTESTINE
18
PROCEDURE ON VESSEL BIFURCATION
18
EXCISION OF LESION OF OTHER SOFT TISSUE
17
LAPAROSCOPIC LYSIS OF PIRIRENAL OR PERIURETERAL ADHESIONS
17
OPEN AND OTHER SIGMOIDECTOMY
17
PERCUTANEOUS ABDOMINAL DRAINAGE
17
TOTAL KNEE REPLACEMENT
17
UNILATERAL THYROID LOBECTOMY
17
EXCISION OR DESTRUCTION OF PERITONEAL TISSUE
16
LAPAROSCOPY
16
OPEN AND OTHER RIGHT HEMICOLECTOMY
16
OTHER SMALL-TO-LARGE INTESTINAL ANASTOMOSIS
16
CHOLECYSTECTOMY
15
ENDOVASCULAR IMPLANTATION OF OTHER GRAPH IN ABDOMINAL AORTA
14
OTHER OPEN UMBILICAL HERNIORRHAPHY
14
SINGLE INTERNAL MAMMARY-CORONARY ARTERY BYPASS
14
TRANSURETHRAL REMOVAL OF OBSTRUCTION FROM URETER
14
OTHER AND OPEN REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL WITH
13
OTHER CYSTOSCOPY
13
OTHER LOCAL EXCISION OR DESTRUCTION OF LESION OR TISSUE OF
13
OTHER LYSIS OF PERIRENAL OR PERIURETERAL ADHESIONS
13
OPEN AND OTHER LEFT HEMICOLECTOMY
12
OPEN AND OTHER REPLACEMENT OF AORTIC VALVE WITH TISSUE GRAFT
12
OTHER INCISION OF PLEURA
12
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Table 4.
Procedures performed on more than one patient.
Procedure
Count
REMOVAL OF INTERNAL FIXATION DEVICE FROM OTHER BONE,
12
UNILATERAL EXTENDED SIMPLE MASTECTOMY
12
ANASTOMOSIS OF SMALL INTESTINE TO ANUS
11
CLOSURE OF FISTULA OF SMALL INTESTINE, EXCEPT DUODENUM
11
COLOSTOMY, NOT OTHERWISE SPECIFIED
11
FUSION OR REFUSION OF 4-8 VERTEBRAE
11
INCISION OF ABDOMINAL WALL
11
INSERTION OF ENDOTRACHEAL TUBE
11
LAPAROSCOPIC REMOVAL OF GASTRIC RESTRICTIVE DEVICE(S)
11
LAPAROSCOPIC TOTAL INTRA-ABDOMINAL COLECTOMY
11
ESOPHAGOMYOTOMY
10
INSERTION OF BREAST TISSUE EXPANDER
10
INSERTION OF NON-DRUG-ELUTING PERIPHERAL (NON-CORONARY) VESSEL STENT(S)
10
LAPAROSCOPIC LEFT HEMICOLECTOMY
10
OTHER HERNIA REPAIR
10
OTHER TRANSURETHRAL PROSTATECTOMY
10
PERCUT NEPHROST W FRAGMN
10
PERCUTANEOUS PYELOGRAM
10
ARTERIOGRAPHY OF OTHER INTRA-ABDOMINAL ARTERIES
9
CLOSURE OF SKIN AND SUBCUTANEOUS TISSUE OTHER SITES
9
INCISIONAL HERNIA REPAIR
9
INSERTION OF OTHER (NASO-)GASTRIC TUBE
9
OTHER KIDNEY TRANSPLANTATION
9
OTHER PARATHYROIDECTOMY
9
OTHER PROCTOPEXY
9
RADICAL EXCISION OF OTHER LYMPH NODES
9
REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL
9
TOTAL SPLENECTOMY
9
CORRECTION OF URETEROPELVIC JUNCTION
8
FLEXIBLE SIGMOIDOSCOPY
8
OTHER REPAIR AND PLASTIC OPERATIONS ON SPINAL CORD STRUCTURES
8
OTHER TRANSURETHRAL EXCISION OR DESTRUCTION OF
8
REVISION OF STOMA OF SMALL INTESTINE
8
(AORTO)CORONARY BYPASS OF ONE CORONARY ARTERY
7
(AORTO)CORONARY BYPASS OF TWO CORONARY ARTERY
7
AORTOGRAPHY
7
EXCISION OR DESTRUCTION OF LESION OR TISSUE OF ABDOMINAL
7
ILEOSTOMY, NOT OTHERWISE SPECIFIED
7
INJECTION INTO THORACIC CAVITY
7
INSERTION OF ONE VASCULAR STENT
7
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Table 4.
Procedures performed on more than one patient.
Procedure
LAPAROSCOPIC CECECTOMY
LUMBAR AND LUMBOSACRAL FUSION OF THE ANTERIOR COLUMN, POSTERIOR
NONEXCISIONAL DEBRIDEMENT OF WOUND, INFECTION, OR BURN
OTHER AND UNSPECIFIED PARTIAL EXCISION OF LARGE INTESTINE
OTHER ENDOVASCULAR PROCEDURES ON OTHER VESSELS
OTHER REPAIR OF ANAL SPHINCTER
RECONSTRUCTION OF URINARY BLADDER
REPAIR OF PERICOLOSTOMY HERNIA
THORACOSCOPIC SEGMENTAL RESECTION OF LUNG
UNILATERAL SIMPLE MASTECTOMY
AORTA-ILIAC-FEMORAL BYPASS
APPLICATION OR ADMINISTRATION OF AN ADHESION BARRIER SUBSTANCE
CLOSED BIOPSY OF LIVER
COLONOSCOPY
EXCISION OF AXILLARY LYMPH NODE
INTRAVENOUS PYELOGRAM
LAPAROSCOPIC INCISIONAL HERNIA REPAIR WITH GRAFT OR PROSTHESIS
OTHER EXCISION OF JOINT OF OTHER SPECIFIED SITE
OTHER EXCISION OR DESTRUCTION OF LESION OR TISSUE OF BRAIN
OTHER GASTROSTOMY
OTHER MAMMOPLASTY
OTHER PARTIAL THYROIDECTOMY
OTHER PERMANENT ILEOSTOMY
OTHER PROSTATECTOMY
OTHER REPAIR OF CEREBRAL MENINGES
PELVIC EVISCERATION
PROCEDURE ON THREE VESSELS
RETROPUBIC PROSTATECTOMY
SUTURE OF LACERATION OF SMALL INTESTINE, EXCEPT DUODENUM
TRANSPLANT FROM CADAVER
DILATION OF URETHRA
EXCISIONAL DEBRIDEMENT OF WOUND, INFECTION, OR BURN
EXPLORATORY LAPAROTOMY
LAPAROSCOPIC ABDOMINOPERINEAL RESECTION OF THE RECTUM
MEDIASTINOSCOPY
OPEN ABDOMINOPERINEAL RESECTION OF THE RECTUM
OTHER AND OPEN REPAIR OF UMBILICAL HERNIA WITH GRAFT OR PROSTHESIS
OTHER APPENDECTOMY
OTHER ENTEROSTOMY
OTHER GASTROENTEROSTOMY WITHOUT GASTRECTOMY
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Count
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5

Table 4.
Procedures performed on more than one patient.
Procedure
Count
OTHER INCISION OF SMALL INTESTINE
OTHER LOCAL DESTRUCTION OR EXCISION OF RENAL LESION OR TISSUE
OTHER PROCEDURES FOR CREATION OF ESOPHAGOGASTRIC
OTHER SKIN GRAFT TO OTHER SITES
PARTIAL GASTRECTOMY WITH ANASTOMOSIS TO JEJUNUM
PARTIAL HEPATECTOMY
REOPENING OF RECENT LAPAROTOMY SITE
REPLACEMENT OF VENTRICULAR SHUNT
REVERSE TOTAL SHOULDER REPLACEMENT
SMALL-TO-SMALL INTESTINAL ANASTOMOSIS
THERAPEUTIC APHERESIS NEC
THORACENTESIS
ABD AORTA RESECT W REPL
ABDOMINAL PROCTOPEXY
ANTERIOR RESECTION OF RECTUM WITH SYNCHRONOUS COLOSTOMY
ARTERIOGRAPHY OF CEREBRAL ARTERIES
ATTACHMENT OF PEDICLE OR FLAP GRAFT TO OTHER SITES
BILATERAL SIMPLE MASTECTOMY
ELECTROMYOGRAPHY
ENDOVASCULAR IMPLANTATION OF BRANCHING OR FENESTRATED GRAFT(S) IN AORTA
EXCISION OF BONE FOR GRAFT, UNSPECIFIED SITE
EXCISION OR DESTRUCTION OF LESION OF CHEST WALL
EXCISION OR DESTRUCTION OF LESION OF SPINAL CORD
EXCISION OR DESTRUCTION OF LESION OR TISSUE OF MEDIASTINUM
INCISION OF LOWER LIMB ARTERIES
INCISION OF PERIRECTAL TISSUE
ISOLATION OF SEGMENT OF SMALL INTESTINE
LAPAROSCOPIC LIVER BIOPSY
LOCAL EXCISION OF OTHER LESION OR TISSUE OF STOMACH
MULTIPLE SEGMENTAL RESECTION OF SMALL INTESTINE
NEPHROTOMY
OTHER AMPUTATION BELOW KNEE
OTHER AND OPEN REPAIR OF INDIRECT INGUINAL HERNIA WITH GRAFT
OTHER AND UNSPECIFIED TOTAL ABDOMINAL HYSTERECTOMY
OTHER AND UNSPECIFIED TOTAL INTRA-ABDOMINAL COLECTOMY
OTHER CERVICAL FUSION OF THE POSTERIOR COLUMN, POSTERIOR TECHNIQUE
OTHER FASCIECTOMY
OTHER GENITOURINARY INSTILLATION
OTHER INCIDENTAL APPENDECTOMY
OTHER PULL-THROUGH RESECTION OF RECTUM
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5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

Table 4.
Procedures performed on more than one patient.
Procedure
Count
OTHER REPAIR OF ABDOMINAL WALL
4
OTHER REVISION OF VASCULAR PROCEDURE
4
OTHER SUTURE OF MUSCLE OR FASCIA
4
PARTIAL CYSTECTOMY
4
PARTIAL EXCISION OF PITUITARY GLAND, TRANSSPHENOIDAL APPROACH
4
PERITONEAL LAVAGE
4
REFUSION OF LUMBAR AND LUMBOSACRAL SPINE, POSTERIOR COLUMN, POSTERIOR
4
RESECTION OF OTHER THORACIC VESSELS WITH REPLACEMENT
4
RIGID PROCTOSIGMOIDOSCOPY
4
SUPRAPUBIC PROSTATECTOMY
4
THORACOSCOPIC DECORTICATION OF LUNG
4
ARTERIOGRAPHY OF OTHER SPECIFIED SITES
3
ARTHROCENTESIS
3
CLIPPING OF ANEURYSM
3
CLOSED BIOPSY OF BRONCHUS
3
CLOSED REDUCTION OF MANDIBULAR FRACTURE
3
CLOSURE OF ANAL FISTULA
3
CLOSURE OF OTHER GASTRIC FISTULA
3
COMPLETE SUBSTERNAL THYROIDECTOMY
3
CONTROL OF HEMORRHAGE, NOT OTHERWISE SPECIFIED
3
DECAPSULATION OF KIDNEY
3
DECOMPRESSION OF TRIGEMINAL NERVE ROOT
3
INCISION WITH REMOVAL OF FOREIGN BODY OR DEVICE FROM SKIN AND
3
INSERTION OF TWO VASCULAR STENTS
3
LAPAROSCOPIC INCIDENTAL APPENDECTOMY
3
LOCAL EXCISION OF RECTAL LESION OR TISSUE
3
OPEN AND OTHER REPLACEMENT OF AORTIC VALVE
3
OPEN HEART VALVULOPLASTY OF AORTIC VALVE WITHOUT REPLACEMENT
3
OPEN OSTEOPLASTY (OSTEOTOMY) OF MANDIBULAR RAMUS
3
OPEN TOTAL INTRA-ABDOMINAL COLECTOMY
3
OTHER AND OPEN REPAIR OF DIRECT INGUINAL HERNIA WITH GRAFT
3
OTHER AND UNSPECIFIED SEGMENTAL RESECTION OF LUNG
3
OTHER LAPAROTOMY
3
OTHER LOCAL EXCISION OR DESTRUCTION OF LESION OF KNEE JOINT
3
OTHER OPERATIONS ON LUNG
3
OTHER OPERATIONS ON THORAX
3
OTHER REPAIR OF ANEURYSM
3
OTHER REPAIR OF CHEST WALL
3
OTHER REPAIR OF PENIS
3
PARATHYROID TISSUE REIMPLANTATION
3
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Table 4.
Procedures performed on more than one patient.
Procedure
Count
REMOVAL OF INTERNAL PROSTHESIS OF PENIS
REMOVAL OF PYELOSTOMY AND NEPHROSTOMY TUBE
REOPENING OF LAMINECTOMY SITE
REPAIR OF COLOVAGINAL FISTULA
REPAIR OF RECTOVAGINAL FISTULA
REPAIR OF VERTEBRAL FRACTURE
REVISION OF URETEROINTESTINAL ANASTOMOSIS
SIZE REDUCTION PLASTIC OPERATION
SUBTOTAL MASTECTOMY
SUTURE OF ARTERY
SUTURE OF DUODENAL ULCER SITE
THORACOSCOPIC DRAINAGE OF PLEURAL CAVITY
TOTAL HIP REPLACEMENT
TRANSPLEURAL THORACOSCOPY
ULTRASONIC FRAGMENTATION OF URINARY STONES
URETERONEOCYSTOSTOMY
URETEROSCOPY
VIDEO AND RADIO-TELEMETERED ELECTROENCEPHALOGRAPHIC MONITORING
AMPUTATION ABOVE KNEE
ANASTOMOSIS OF HEPATIC DUCT TO GASTROINTESTINAL TRACT
APPLICATION OF EXTERNAL FIXATOR DEVICE, TIBIA AND FIBULA
APPLICATION OF OTHER WOUND DRESSING
ASPIRATION OF OTHER SOFT TISSUE
BIOPSY OF ABDOMINAL WALL OR UMBILICUS
CLOSED BIOPSY OF BLADDER
COMPUTER ASSISTED SURGERY WITH CT/CTA
DEBRIDEMENT OF OPEN FRACTURE OF TIBIA AND FIBULA
DENTAL WIRING
DERMAL REGENERATIVE GRAFT
DISTAL PANCREATECTOMY
DORSAL AND DORSOLUMBAR FUSION OF THE ANTERIOR COLUMN, ANTERIOR TECHNIQUE
DORSAL AND DORSOLUMBAR FUSION OF THE POSTERIOR COLUMN, POSTERIOR
ENDARTERECTOMY OF ABDOMINAL ARTERIES
ENDOSCOPIC CONTROL OF GASTRIC OR DUODENAL BLEEDING
ENDOSCOPIC INSERTION OF STENT (TUBE) INTO BILE DUCT
ENDOVASCULAR (TOTAL) EMBOLIZATION OR OCCLUSION OF HEAD AND NECK VESSELS
ESOPHAGOGASTRODUODENOSCOPY (EGD) WITH CLOSED BIOPSY
EXCISION OF DEEP CERVICAL LYMPH NODE
EXCISION OF HEMORRHOIDS
EXCISION OF INGUINAL LYMPH NODE
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3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

Table 4.
Procedures performed on more than one patient.
Procedure
Count
EXCISION OF LESION OR TISSUE OF CEREBRAL MENINGES
EXCISION OF LESION OR TISSUE OF DIAPHRAGM
EXCISION OR DESTRUCTION OF OTHER LESION OR TISSUE OF HEART, OPEN
EXTRACRANIAL-INTRACRANIAL (EC-IC)VASCULAR BYPASS
FASCIOTOMY
FAT GRAFT OF SKIN AND SUBCUTANEOUS TISSUE
GASTROPEXY
IMPLANTATION OR REPLACEMENT OF PERIPHERAL NEUROSTIMULATOR LEAD(S)
INCISION OF ABDOMINAL VEINS
INCISION OF CEREBRAL MENINGES
INCISION OF PERIANAL ABSCESS
INCISION OF UPPER LIMB VESSELS
INSERTION OF CATHETER INTO SPINAL CANAL FOR INFUSION OF THERAPEUTIC
INSERTION OF RECOMBINANT BONE MORPHOGENETIC PROTEIN
INSERTION OR REPLACEMENT OF EXTERNAL VENTRICULAR DRAIN (EVD)
INTRA-ABDOMINAL MANIPULATION OF LARGE INTESTINE
LAPAROSCOPIC REMOVAL OF BOTH OVARIES AND TUBES AT SAME OPERATIVE EPISODE
LATISSIMUS DORSI MYOCUTANEOUS FLAP
LOBECTOMY OF LIVER
LOCAL EXCISION OF LESION OR TISSUE OF OTHER BONE, EXCEPT
NEPHROSCOPY
NEPHROSTOMY
OBLITERATION AND TOTAL EXCISION OF VAGINA
OPEN AND OTHER RESECTION OF TRANSVERSE COLON
OPEN BIOPSY OF BRAIN
OPEN REDUCTION OF MANDIBULAR FRACTURE
OTHER ABDOMINOPERINEAL RESECTION OF THE RECTUM
OTHER AND OPEN REPAIR OF DIRECT INGUINAL HERNIA
OTHER AND OPEN REPAIR OF INDIRECT INGUINAL HERNIA
OTHER AND UNSPECIFIED PNEUMONECTOMY
OTHER AND UNSPECIFIED ROBOTIC ASSISTED PROCEDURE
OTHER AND UNSPECIFIED SUBTOTAL ABDOMINAL HYSTERECTOMY
OTHER AND UNSPECIFIED THORACOSCOPIC OPERATIONS ON THYMUS
OTHER CRANIAL OSTEOPLASTY
OTHER CRANIOTOMY
OTHER ELECTRIC ERSHOCK OF HEART
OTHER IRRIGATION OF WOUND
OTHER LAPAROSCOPIC REPAIR OF OTHER HERNIA OF ANTERIOR ABDOMINAL WALL
OTHER MYECTOMY
OTHER PARTIAL PANCREATECTOMY
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2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

Table 4.
Procedures performed on more than one patient.
Procedure
OTHER PYLOROPLASTY
OTHER REPAIR OF BLADDER
OTHER REPAIR OF INTESTINE
OTHER REPAIR OF STOMACH
OTHER REVISION OF STOMA OF LARGE INTESTINE
OTHER SUPRAPUBIC CYSTOSTOMY
OTHER UNILATERAL FEMORAL HERNIORRHAPHY
OTHER UNILATERAL SALPINGO-OOPHORECTOMY
OTHER URETHROSCOPY
PEDICLE GRAFT TO BREAST
PERCUTANEOUS ASPIRATION OF KIDNEY (PELVIS)
PLICATION OF VENA CAVA
PULL-THROUGH RESECTION OF RECTUM, NOT OTHERWISE SPECIFIED
PULMONARY ARTERY WEDGE MONITORING
RADICAL GROIN DISSECTION
RADICAL NECK DISSECTION, UNILATERAL
REFUSION OF LUMBAR AND LUMBOSACRAL SPINE, ANTERIOR COLUMN, ANTERIOR
REMOVAL OF TRANSPLANTED OR REJECTED KIDNEY
REOPENING OF WOUND OF THYROID FIELD
REPAIR OF DIAPHRAGMATIC HERNIA WITH THORACIC APPROACH,
REPAIR OF DIAPHRAGMATIC HERNIA, ABDOMINAL APPROACH, NOT OTHERWISE
REPAIR OF FISTULA INVOLVING BLADDER AND INTESTINE
REPAIR OF RECTOCELE
REVISION OF AMPUTATION STUMP
REVISION RHINOPLASTY
SEGMENTAL OSTEOPLASTY (OSTEOTOMY) OF MAXILLA
SUTURE OF GASTRIC ULCER SITE
SUTURE OF LACERATION OF DIAPHRAGM
SUTURE OF LACERATION OF LIP
SUTURE OF LACERATION OF RECTUM
THORACOSCOPIC PLEURAL BIOPSY
TOTAL URETERECTOMY
TRANSPLANT FROM LIVE NON-RELATED DONOR
TRANSURETHRAL CLEARANCE OF BLADDER
UNILATERAL ADRENALECTOMY
UNILATERAL REPAIR OF INGUINAL HERNIA WITH GRAFT OR
URINARY DIVERSION TO INTESTINE
VAGINAL RECONSTRUCTION
VENTRICULAR SHUNT TO ABDOMINAL CAVITY AND ORGANS
(AORTO)CORONARY BYPASS OF THREE CORONARY ARTERIES
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Count
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
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Table 6.
Frequency of postoperative day one and two pain medications.

Medications
IV Narcotic

PO Narcotic
IM Non-Narcotic
IV Non - Narcotic
PO Non-Narcotic

Hydromorphone
Morphine
Fentanyl
Meperidine
Oxycodone
Ketorolac
Acetaminophen
Ibuprophen

Postoperative Day 1
Postoperative Day 2
1478 (86.7%)
310 (18.2%)
478 (28.1%)
114 (6.7%)
49 (2.9%)
17 (1%)
52 (3.1%)
4 (.2%)
92 (5.4%
144 (8.5%)
131 (7.7%
151 (8.9%)
243 (14.3%)
69 (4%)
0 (0%)
2 (.1 %)
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Table 7.
Descriptive statistics for total dose in mg of each pain medication administered during
postoperative day one and two.

Medications

Postoperative Day 1
Postoperative Day 2
Mean
Min
Max Std Dev Mean
Min Max Std Dev
Hydromorphone
2.44
0.25 203
5.53
2.19 0.25 105
6.75
Morphine
7.84
0.25
60
6.31
7.55
1
45
8.21
Fentanyl
170.37
0.25 700 171.65 187.67
2.5 850 212.45
Meperidine
29.33
12.5 225
30
90.63 12.5 225
93.19
Oxycodone
28.07
5 380
51.1
18
5
95
14.74
Ketorolac
28.4
1
90
13.33
27.65
15 105
14.2
Acetaminophen
1068.72
650 2000 269.53 1030.68
10 2000 261.45
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Table 8.
Descriptive statistics of total postoperative day 1 and day 2 morphine equivalent dose.
BMI Category
Normal

Overweight

Obesity Class I

Obesity Class II

Obesity Class III

Total

N
Mean
Minimum
Maximum
Std. Deviation
% of Total N
N
Mean
Minimum
Maximum
Std. Deviation
% of Total N
N
Mean
Minimum
Maximum
Std. Deviation
% of Total N
N
Mean
Minimum
Maximum
Std. Deviation
% of Total N
N
Mean
Minimum
Maximum
Std. Deviation
% of Total N
N
Mean
Minimum
Maximum
Std. Deviation
% of Total N

Total 24-Hour Morphine Equivalent Dose
352.0
20.9
1.3
232.5
23.6
21.6%
346.0
18.8
2.5
117.3
12.1
21.3%
349.0
22.0
1.3
570.0
35.4
21.4%
278.0
26.8
1.3
1015.0
67.7
17.1%
303.0
18.1
2.5
103.8
17.7
18.6%
1628.0
21.2
1.3
1015.0
35.6
100.0%
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Total 48-Hour Morphine Equivalent Dose
115.0
16.4
2.5
157.5
20.6
22.0%
95.0
24.4
0.6
525.0
56.4
18.2%
125.0
19.2
2.5
142.5
19.9
23.9%
97.0
21.1
1.3
84.0
21.0
18.5%
91.0
20.1
2.5
142.5
22.1
17.4%
523.0
20.0
0.6
525.0
30.5
100.0%
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Table 10.
Multiple comparisons between Age and BMI.
Dependent Variable: Age
Tukey HSD
(I) BMI Category
Normal

Overweight

Mean Difference
(I-J)

Std.
Error

Sig.

Overweight

-0.88

1.136

.937

-3.99

2.22

Obesity Class I

1.48

1.136

.687

-1.62

4.59

Obesity Class II

4.936*

1.206

.000

1.64

8.23

Obesity Class III

10.997*

1.178

.000

7.78

14.21

Normal

0.88

1.136

.937

-2.22

3.99

Obesity Class I

2.37

1.136

.227

-.73

5.47

Obesity Class II

5.821*

1.206

.000

2.53

9.12

1.178

.000

8.67

15.10

Obesity Class III
Obesity Class I

Obesity Class II

Obesity Class III

11.882

*

95% Confidence Interval
Lower Bound Upper Bound

Normal

-1.48

1.136

.687

-4.59

1.62

Overweight

-2.37

1.136

.227

-5.47

.73

3.451

*

1.206

.035

.16

6.75

Obesity Class III

9.512

*

1.178

.000

6.30

12.73

Normal

-4.936*

Obesity Class II

1.206

.000

-8.23

-1.64

Overweight

-5.821

*

1.206

.000

-9.12

-2.53

Obesity Class I

-3.451*

1.206

.035

-6.75

-.16

Obesity Class III

6.062

*

1.245

.000

2.66

9.46

Normal

-10.997

*

1.178

.000

-14.21

-7.78

Overweight

-11.882*

Obesity Class I
Obesity Class II

1.178

.000

-15.10

-8.67

-9.512

*

1.178

.000

-12.73

-6.30

-6.062

*

1.245

.000

-9.46

-2.66

*. The mean difference is significant at the 0.05 level.
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Table 11.
Crosstabulation between BMI and Gender.
BMI Category

Gender
Male

Normal

Overweight

Obesity Class I

Obesity Class II

Obesity Class III

Total

Count
% within BMI Category
% within Gender
Count
% within BMI Category
% within Gender
Count
% within BMI Category
% within Gender
Count
% within BMI Category
% within Gender
Count
% within BMI Category
% within Gender
Count
% within BMI Category
% within Gender
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169
46.3%
22.0%
212
58.1%
27.6%
170
46.6%
22.1%
123
42.3%
16.0%
94
29.6%
12.2%
768
45.1%
100%

Female
196
53.7%
20.9%
153
41.9%
16.3%
195
53.4%
20.8%
168
57.7%
17.9%
224
70.4%
23.9%
936
54.9%
100%

Total
365
100%
21.4%
365
100%
21.4%
365
100%
21.4%
291
100%
17.1%
318
100%
18.7%
1704
100%
100%

100

101

102

103
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Table 17.
Multiple comparisons between the log transformed postoperative day one total oral
morphine equivalent dose and BMI.

(I) BMI Category
Normal

Overweight

Obesity Class I

Obesity Class II

Obesity Class III

Overweight
Obesity Class I
Obesity Class II
Obesity Class III
Normal
Obesity Class I
Obesity Class II
Obesity Class III
Normal
Overweight
Obesity Class II
Obesity Class III
Normal
Overweight
Obesity Class I
Obesity Class III
Normal
Overweight
Obesity Class I
Obesity Class II

Mean
Difference (I-J)
-.11
-.01
-.05
.09
.11
.10
.06
.20*
.01
-.10
-.04
.10
.05
-.06
.04
.14
-.09
-.20*
-.10
-.14
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Std. Error
.05
.06
.07
.06
.05
.05
.06
.06
.06
.05
.07
.06
.07
.06
.07
.07
.06
.06
.06
.07

Sig.
.30
1.00
.96
.57
.30
.36
.89
.00
1.00
.36
.97
.52
.96
.89
.97
.26
.57
.00
.52
.26

95% Confidence Interval
Lower
Upper
Bound
Bound
-.25
.04
-.18
.16
-.24
.14
-.08
.27
-.04
.25
-.05
.25
-.11
.23
.05
.35
-.16
.18
-.25
.05
-.23
.15
-.07
.27
-.14
.24
-.23
.11
-.15
.23
-.05
.33
-.27
.08
-.35
-.05
-.27
.07
-.33
.05
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107

108

109

110

111

Table 21.
Descriptive statistics for postop day 1 regression variables.

Mean
Std. Deviation
2.6788
0.8167
56.9798
15.8488
3.4575
0.2610

Log transformed total morphine equivalent
Age
Log transformed BMI
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N
1581
1581
1581

Table 22.
Bivariate correlation - hierarchical regression outliers intact - postop day 1.

Pearson Correlation

ln_total_24_equiv
age
ln_bmi
* p<.05. **p<.01. ***p<.001.

ln_total_24_
equiv
1.000
-.077**
-.059*
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age
1.000
-.264***

ln_bmi

1.000

Table 23.
Bivariate and partial correlations between log transformed total morphine equivalent
dose on postop day 1 and predictor variables – hierarchical regression outliers intact.

Bivariate Correlation
Partial Correlations
Age
-.077**
-.095***
ln_bmi
-.059*
-.078**
* p<.05. **p<.01. ***p<.001.
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Table 25.
Bivariate correlations - hierarchical regression outliers removed - postop day 1.

Pearson
ln_total_24_equiv
Correlation age
ln_bmi
**p<.01. ***p<.001.

ln_total_24_equiv
age
ln_bmi
1.000
-.067**
1.000
-.059** -.261***
1.000
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Table 26.
Bivariate and partial correlations between log transformed total morphine equivalent
dose on postop day 1 and predictor variables – hierarchical regression outliers
removed.

Age
ln_bmi
**p<.01. ***p<.001.

Bivariate Correlation
Partial Correlations
-.067**
-.090***
-.059**
-.078**
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Table 28.
Descriptive statistics for postop day 2 regression variables.

Mean
Std. Deviation
2.5287
.93357
55.64
16.213
3.4499
.26474

Log transformed total morphine equivalent
Age
Log transformed BMI
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N
511
511
511

Table 29.
Bivariate correlations - hierarchical regression outliers intact - postop day 2.

Pearson
ln_total_48_equiv
Correlation Age
ln_bmi
***p<.001.

ln_total_48_equiv
age
ln_bmi
1.000
-.079
1.000
.043 -.214***
1.000
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Table 30.
Bivariate and partial correlations between log transformed total morphine equivalent
dose on postop day 2 and predictor variables – hierarchical regression outliers intact.

Age
ln_bmi
* p<.05. **p<.01.

Bivariate Correlation Partial Correlations
-.079
-.077
.043
.023

121

122

Table 32.
Bivariate correlations - hierarchical regression outliers removed - postop day 2.

Pearson
Correlation

ln_total_48_equiv
Age
ln_bmi

ln_total_48_
equiv
1.000
-.076
.074

***p<.001.
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age
1.000
-.184***

ln_bmi

1.000

Table 33.
Bivariate and partial correlations between log transformed total morphine equivalent
dose on postop day 2 and predictor variables – hierarchical regression outliers
removed.

Age
ln_bmi
* p<.05.

Bivariate Correlation Partial Correlations
-.076
-.063
.074
.062
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Figure 1.
Frequency distribution of total postoperative day 1 oral morphine equivalent dose
prior to transformation.
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Figure 2.
Frequency distribution of total postoperative day two oral morphine equivalent dose
prior to transformation.

127

Figure 3.
Q-Q of total postoperative day one oral morphine equivalent dose prior to
transformation.
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Figure 4.
Q-Q of total postoperative day two oral morphine equivalent dose prior to
transformation.
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Figure 5.
Logarithmic transformed total postoperative day 1 oral morphine equivalent dose.
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Figure 6.
Logarithmic transformed total postoperative day 2 oral morphine equivalent dose.
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Figure 7.
Q-Q of log transformed total postoperative day one oral morphine equivalent dose.
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Figure 8.
Q-Q of log transformed total postoperative day one oral morphine equivalent dose.
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Figure 9.
Mean plot of the log transformed total postop day one morphine equivalent dose X
BMI.

134

Figure 10.
Residual histogram for total postop day 1 morphine equivalent dose.
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Figure 11.
P-P plot of regression standardized residual for total postop day 1 morphine equivalent
dose.
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Figure 12.
Scatterplot of standardized residuals and standardized predicted values of total postop
day 1 oral morphine equivalent dose.
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Figure 13.
Scatterplot of standardized residuals and standardized predicted values of the natural
log transformed total postop day 1 oral morphine equivalent dose.
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Figure 14.
Scatterplot of standardized residuals and standardized predicted values of the natural
log transformed total postop day 1 oral morphine equivalent dose DV and natural log
transformed IV, BMI.
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Figure 15.
Normal distribution of regression standardized residual for the natural log transformed
total postop day 1 morphine equivalent dose DV and the natural log transformed IV,
BMI.
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Figure 16.
P-P plot of regression standardized residual for the natural log transformed total
postop day 1 morphine equivalent dose and natural log transformed BMI.
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Figure 17.
Scatterplot of natural log transformed total postop day 1 morphine equivalent dose and
transformed BMI variables.
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Figure 18.
Normal distribution of regression standardized residual – hierarchical regression with
outliers intact – postop day 1.
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Figure 19.
P-P plot of regression standardized residual – hierarchical regression outliers intact –
postop day 1.
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Figure 20.
Scatterplot of standardized residuals and standardized predicted values – hierarchical
regression outliers intact – postop day 1.
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Figure 21.
Partial regression plot of log transformed total postop day 1 morphine equivalent dose
X age – hierarchical regression outliers intact.
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Figure 22.
Partial regression plot of log transformed total postop day 1 morphine equivalent dose
X log transformed BMI – hierarchical regression outliers intact.
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Figure 23.
Normal distribution of regression standardized residual – hierarchical regression with
outliers removed – postop day 1.
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Figure 24.
P-P plot of regression standardized residual – hierarchical regression outliers removed
– postop day 1.
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Figure 25.
Scatterplot of standardized residuals and standardized predicted values – hierarchical
regression outliers removed – postop day 1.

150

Figure 26.
Partial regression plot of log transformed total postop day 1 morphine equivalent dose
X age – hierarchical regression outliers removed.
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Figure 27.
Partial regression plot of log transformed total postop day 1 morphine equivalent dose
X log transformed BMI – hierarchical regression outliers removed.
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Figure 28.
Residual histogram for total postop day 2 morphine equivalent dose.
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Figure 29.
P-P plot of regression standardized residual for total postop day 2 morphine equivalent
dose.
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Figure 30.
Scatterplot of standardized residuals and standardized predicted values of total postop
day 2 oral morphine equivalent dose.
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Figure 31.
Scatterplot of standardized residuals and standardized predicted values of the natural
log transformed total postop day 2 oral morphine equivalent dose.
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Figure 32.
Scatterplot of standardized residuals and standardized predicted values of the natural
log transformed total postop day 2 oral morphine equivalent dose DV and natural log
transformed IV, BMI.
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Figure 33.
Normal distribution of regression standardized residual for the natural log transformed
total postop day 2 morphine equivalent dose DV and the natural log transformed IV,
BMI.
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Figure 34.
P-P plot of regression standardized residual for the natural log transformed total
postop day 2 morphine equivalent dose and natural log transformed BMI.
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Figure 35.
Scatterplot of natural log transformed total postop day 2 morphine equivalent dose and
transformed BMI variables.
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Figure 36.
Normal distribution of regression standardized residual – hierarchical regression with
outliers intact – postop day 2.
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Figure 37.
P-P plot of regression standardized residual – hierarchical regression outliers intact –
postop day 2.
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Figure 38.
Scatterplot of standardized residuals and standardized predicted values – hierarchical
regression outliers intact – postop day 2.
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Figure 39.
Partial regression plot of log transformed total postop day 2 morphine equivalent dose
X age – hierarchical regression outliers intact.
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Figure 40.
Partial regression plot of log transformed total postop day 2 morphine equivalent dose
X log transformed BMI– hierarchical regression outliers intact.
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Figure 41.
Normal distribution of regression standardized residual – hierarchical regression with
outliers removed – postop day 2.

166

Figure 42.
P-P plot of regression standardized residual – hierarchical regression outliers removed
– postop day 2.
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Figure 43.
Scatterplot of standardized residuals and standardized predicted values – hierarchical
regression outliers removed – postop day 2.
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Figure 44.
Partial regression plot of log transformed total postop day 2 morphine equivalent dose
X age – hierarchical regression outliers intact.
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Figure 45.
Partial regression plot of log transformed total postop day 2 morphine equivalent dose
X log transformed BMI– hierarchical regression outliers removed.
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